# EDGAR Filing Document

**Accession Number:** 0001934348
**File Stem:** 0001669191-23-000305
**Filing Date:** 2023-3
**Character Count:** 182121
**Document Hash:** 24ed9caf963422056a359e7b942e9dff
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001669191-23-000305.hdr.sgml**: 20230331

**ACCESSION NUMBER**: 0001669191-23-000305

**CONFORMED SUBMISSION TYPE**: C/A

**PUBLIC DOCUMENT COUNT**: 8

**FILED AS OF DATE**: 20230331

**DATE AS OF CHANGE**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CliqRex Inc.
- **CENTRAL INDEX KEY:** 0001934348
- **IRS NUMBER:** 874706737
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C/A
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-30414
- **FILM NUMBER:** 23786881

**BUSINESS ADDRESS:**
- **STREET 1:** 1569 HOLLYWOOD AVE
- **CITY:** CINCINNATI
- **STATE:** OH
- **ZIP:** 45224
- **BUSINESS PHONE:** 4047914591

**MAIL ADDRESS:**
- **STREET 1:** 1569 HOLLYWOOD AVE
- **CITY:** CINCINNATI
- **STATE:** OH
- **ZIP:** 45224

## Ex-99

html![](offeringpage.jpg)

### Attached PDF Documents

**Attachment 1:** `offeringstatement.pdf`

# Offering Statement for CliqRex Inc.

('CliqRex,' 'we,' 'our,' or the 'Company')

This document is generated by a website that is operated by Netcapital Systems LLC ('Netcapital'), which is not a registered broker-dealer. Netcapital does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities listed here are being offered by, and all information included in this document are the responsibility of, the applicable issuer of such securities. Netcapital has not taken any steps to verify the adequacy, accuracy or completeness of any information. Neither Netcapital nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy or completeness of any information in this document or the use of information in this document.

All Regulation CF offerings are conducted through Netcapital Funding Portal Inc. ('Portal'), an affiliate of Netcapital, and a FINRA/SEC registered funding-portal. For inquiries related to Regulation CF securities activity, contact Netcapital Funding Portal Inc.:

**Paul Riss:**

paul@netcapital.com

Netcapital and Portal do not make investment recommendations and no communication, through this website or in any other medium, should be construed as a recommendation for any security offered on or off this investment platform. Equity crowdfunding investments in private placements, Regulation A, D and CF offerings, and start-up investments in particular are speculative and involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest in start-ups. Companies seeking startup investments through equity crowdfunding tend to be in earlier stages of development and their business model, products and services may not yet be fully developed, operational or tested in the public marketplace. There is no guarantee that the stated valuation and other terms are accurate or in agreement with the market or industry valuations. Additionally, investors may receive illiquid and/or restricted stock that may be subject to holding period requirements and/or liquidity concerns. In the most sensible investment strategy for start-up investing, start-ups should only be part of your overall investment portfolio. Further, the start-up portion of your portfolio may include a balanced portfolio of different start-ups. Investments in startups are highly illiquid and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest.

The information contained herein includes forward-looking statements. These statements relate to future events or to future financial performance, and involve known and unknown risks, uncertainties, and other factors, that may cause actual results to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond the company's control and which could, and likely will, materially affect actual results, levels of activity, performance, or achievements. Any forward-looking statement reflects the current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. No obligation exists to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

## The Company

**1. What is the name of the issuer?**

CliqRex Inc.

1569 Hollywood Ave

Cincinnati, OH 45224

## Eligibility

**2. The following are true for CliqRex Inc. :**

- Organized under, and subject to, the laws of a State or territory of the United States or the District of Columbia.
- Not subject to the requirement to file reports pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934.
- Not an investment company registered or required to be registered under the Investment Company Act of 1940.
- Not ineligible to rely on this exemption under Section 4(a)(6) of the Securities Act as a result of a disqualification specified in Rule 503(a) of Regulation Crowdfunding. (For more information about these disqualifications, see Question 30 of this Question and Answer format).
- Has filed with the Commission and provided to investors, to the extent required, the ongoing annual reports required by Regulation Crowdfunding during the two years immediately preceding the filing of this offering statement (or for such shorter period that the issuer was required to file such reports).
- Not a development stage company that (a) has no specific business plan or (b) has indicated that its business plan is to engage in a merger or acquisition with an unidentified company or companies.

**3. Has the issuer or any of its predecessors previously failed to comply with the ongoing reporting requirements of Rule 202 of Regulation Crowdfunding?**

Issuer needs to certify.

## Directors, Officers and Promoters of the Company

**4. The following individuals (or entities) represent the company as a director, officer or promoter of the offering:**

*Name*

Pete Mastin

*Principal occupation and employment responsibilities during at least the last three (3) years with start and ending dates*

| Start Date | End Date | Company | Position / Title |
| --- | --- | --- | --- |
| 03/14/2016 | 04/30/2020 | Jolokia | CEO |
| 01/20/2022 | Present | CliqRex Inc. | COO |
| 07/01/2021 | 05/01/2022 | Learnie | CEO |

Short Bio: Pete is passionate about making Internet video better (because there is a lot to improve), as well as learning and development (L&D). He enjoys exploring new use cases for video that improve the human condition. Pete enjoys speaking at conferences such as NAB (National Association of Broadcasters), Streaming Media, The CDN/Cloud World Conference (Hong Kong), Velocity, Content Delivery Summit, Digital Hollywood and Interop (among others). He participated in projects with the Department of Artificial Intelligence at the University of Georgia developing software for evaluating logics. Interest: AI, Interactive Moving Pictures (video), AR/VR, Content Delivery Networks, Business Strategy, Media, Streaming, Knowledge Engineering, Architecture, Leadership, People, Motivation Pete has an undergraduate and masters degree from the University of Georgia. Go Dogs. Work Experience: https://www.linkedin.com/in/petemastin/

# Name

Timur Akilov

# Principal occupation and employment responsibilities during at least the last three (3) years with start and ending dates

| Start Date | End Date | Company | Position / Title |
| --- | --- | --- | --- |
| 01/01/2019 | Present | Pixaura Digital LLC | Co-Founder and President |
| 03/24/2015 | 02/05/2020 | ETI Empire Holdings LLC | Managing Partner |
| 01/03/2019 | Present | Alpha Citadel Ventures LLC | Founder and CEO |
| 01/01/2016 | Present | Broadway Realty | Associate Broker |
| 09/01/2005 | Present | TDA Business Corp | President |
| 06/10/2019 | Present | Pixaura Holdings LLC | Manager |
| 01/20/2022 | Present | CliqRex Inc. | Co-Founder and CFO,Treasurer & Secretary |

Short Bio: Timur has been working in the software and IT field since 1999, when he started as a software developer at Computer Associates, one of the leading software companies. His dedication and drive for success have earned him much trust and respect among his colleagues. After Computer Associates, Timur co-founded, led or took part in many interesting software, marketing, investment as well as real estate projects. In 1992, at the age of 15, having immigrated to the United States from the former Soviet Union, Timur started 10th grade at Forest Hills High School in New York. Without prior knowledge of the English language, by working very hard, Timur managed to significantly excel in his studies. Timur holds a B.S. degree in Computer Science from the City University of New York with a minor in Economics. At the University, he was a recipient of the prestigious United Federation of Teachers Scholarship. In 1999, he graduated with Cum Laude honors, the Dean's List Award and membership in the Golden Key National Honor Society. In addition to his love for technology, Timur also possesses a great sense of business management and finance that have helped him succeed in many of his endeavors. In 2015, he co-founded ETI Empire Holdings LLC, a holding company that took part in interesting and lucrative technology and real estate projects. In 2019, Timur founded Alpha Citadel Ventures LLC, a company that promotes innovation and helps startups with their growth strategy and planning. Most recently, he joined with James O'Loughlin to start Pixaura Digital, a very successful agency dedicated to customizing strategies for its clients. In his spare time, you can find Timur practicing martial arts and playing tennis, soccer or basketball with his children. Work Experience: https://www.linkedin.com/in/takilov/

# Name

Gillian Oakenfull

Principal occupation and employment responsibilities during at least the last three (3) years with start and ending dates

| Start Date | End Date | Company | Position / Title |
| --- | --- | --- | --- |
| 10/15/1998 | Present | Miami University | Professor of Marketing |
| 01/20/2022 | Present | CliqRex Inc. | Chief Strategy and Impact Officer |
| 04/01/2004 | Present | EquiCentric Brand Research | Partner |
| 04/21/2021 | Present | Rethink Lab Inc | Owner |

Short Bio: Gillian Oakenfull earned her Ph.D. in Marketing from the University of Houston in 1998. She is the owner of ReThink Lab, a brand-consultancy focused on providing organizations with a different take on diversity that captures the whole consumer and employee through a cultural lens, leading to an outcome beyond inclusion, and providing impact for both growth and good, internally within the organization and externally in the marketplace. Gillian is a contributing writer to Forbes.com with a column on Cultural Leadership in a VUCA World. She has been a member of the faculty of the Farmer School of Business, Miami University since 1998. She recently created the Center for Kickglass Change (@KickglassM) to create social change through Awareness, Agency, and Advancement in education. She led the curricular design of the Farmer School's innovative integrated curriculum for first-year students. Based on her BQ model of Future Work Skills, the integrated curriculum provides students with technical and soft skills required to succeed in a complex business environment driven by globalization, diversity, and technology. She also led the development of Department of Marketing's new skills-based curriculum which focuses on providing students with skills such as analytical reasoning, insight development, strategic thinking and cultural intelligence over traditional marketing content and its new Digital Marketing major. Her research focuses on three areas of expertise (i) social identity and marketing to underrepresented consumers, (ii) measuring brand meaning and brand management, and (iii) work skill development in an organizational setting. Her research has been published in top quality academic journals in both business and the social sciences. These include the Journal of Business Research, the Journal of Advertising Research, the Journal of Public Policy and Marketing, Psychology and Marketing, and Business and Society Review. Dr. Oakenfull is a HBDI® Certified Practitioner, a CQ® Certified Facilitator and Trainer, a Belbin® Team Role Accredited Practitioner, an ICAgile® Certified Professional, and is certified in the Kepner-Tregoe Decision-making and Problem-solving method. She has won numerous national and international teaching and service awards including being named a national finalist in the 2012 US Professor of the Year award program sponsored by the Carnegie Foundation and the Council for Advancement and Support of Education and being named Carnegie Foundation for the Advancement of Teaching Ohio Professor of the Year. She is a citizen of Ireland, the United Kingdom, and the United States. She's a former NCAA Division I student-athlete in three sports [tennis, cross-country, and indoor track] and flirted with the pro tennis circuit. Work Experience: https://www.linkedin.com/in/gillian-oakenfull-ph-d-2551126

#### **Name**

Bob Roman

#### ***Principal occupation and employment responsibilities during at least the last three (3) years with start and ending dates***

| Start Date | End Date | Company | Position / Title |
| --- | --- | --- | --- |
| 09/10/2004 | Present | FIREANT STUDIO, Inc. | Founder / CEO |
| 04/06/2022 | Present | CliqRex Inc. | Chief Product Officer |

Short Bio: With over 20 years of experience in digital marketing, Bob has always been associated with delivering engaging experiences and technical insight across multiple industry verticals and delivering against diverse objectives. For the last 18 years as Founder & CEO of FIREANT STUDIO, Inc., he has strategized and created interactive solutions for global non-profits, organizations focused on underserved communities, higher-education, environmental impact groups and social issues from crisis support to inclusive peer mentoring. Bob possesses a strong passion and desire to create engaging, interactive, rich-media experiences that provide high value at all touch points throughout the digital lifecycle. He embraces the challenges of usability and inclusivity that exists in the increasingly device accessible data-driven world

and throughout his career has focused on providing clarity from complexity. He has worked for a variety of clients ranging from Internet 2, American Express, TD Ameritrade, Aurora Economic Development Council, Rocky Mountain Institute, Expanding the Bench, Colorado Health Network to the World Wildlife Fund. His diverse experience enables him to ensure the core organizational values and goals are accurately reflected throughout all digital points of engagement within the user experience ecosystem. Work Experience: https://www.linkedin.com/in/bobroman/

**Name**

Dara O'Loughlin

***Principal occupation and employment responsibilities during at least the last three (3) years with start and ending dates***

| Start Date | End Date | Company | Position / Title |
| --- | --- | --- | --- |
| 07/25/2019 | Present | North Hills Swim Club | Marketing Outreach |
| 08/09/2018 | Present | University of Cincinnati | Adjunct Professor |
| 08/01/2012 | 12/17/2021 | Independent Contractor | Yoga Teacher and Teacher Trainer |
| 01/20/2022 | Present | CliqRex Inc. | Co-founder/Chief Experience Officer |

Short Bio: Dara is committed to the crafting of meaningful and transformative experiences for others. She has put her heart into developing curricula and teaching coursework in art, technology, and yoga that empowers and enhances lives through creativity and connection. In addition, she has worked together with her husband, James, on creative problem-solving adventures in the pursuit of enhancing the life of their profoundly brain-injured son. Dara was trained as both an artist and educator at Miami University, where she met James and received her BFA and BS in Art Education. Dara and James have successfully worked together professionally in several places. First, it was at a small elementary school in College Corner, OH where she taught art and James was the "tech guy." Then, they worked together at a marketing firm in Cincinnati, OH. There, she piloted an exciting new Technologist in Residence program that brought much appreciated one-on-one technology education to teachers in Cincinnati Public Schools while James was programming and designing. The successful program expanded with Dara leading other TIRs to share technology that enhanced teachers' and students' lives. It was during her position as a Technologist In Residence that her career had to shift, as she gave birth to a child who would provide James and Dara with the most challenging problem-solving opportunities of their lives. Their son, Emmett, suffered a detrimental lack of oxygen at birth, and now at age 18 is still unable to walk, sit, speak, or even use his hands - though his smile lights up every living soul. Identifying his needs and enhancing his life experiences have required enormous creative problem solving and teamwork. There is something magical about James and Dara working together, whether it's starting a business, raising their three incredible children, or converting a shuttle bus into a medically supportive recreational vehicle for their family to be able to travel with their son, solving problems is where they shine. With an artistic vision and a caring heart, Dara works harmoniously together with James to evolve big transformational ideas into real-life solutions. Work Experience: https://www.linkedin.com/in/dara-oloughlin-3623372b

**Name**

Michael LeFort

***Principal occupation and employment responsibilities during at least the last three (3) years with start and ending dates***

| Start Date | End Date | Company | Position / Title |
| --- | --- | --- | --- |
| 01/01/2021 | Present | Learnie | CMO |
| 05/01/2017 | Present | Social Impact Allies | Managing Partner |
| 04/01/2022 | Present | CliqRex Inc. | CMO |
| 12/01/2017 | 07/01/2019 | Carrot New York | CMO |
| 02/01/2023 | Present | Pixaura Digital LLC | Executive Vice President of Strategy |

Short Bio: Michael is an award-winning brand developer and marketer with an expertise in building go-to-market strategies for brands in technology, education, packaged goods, media and social impact. For 20 years, Michael has developed and led measurable omni-channel campaigns for top brands and nonprofits resulting in sales, brand reach, customer loyalty and impact. Michael is widely regarded as innovative and having a unique ability to create esprit de corps among partners, client and teams, as well as: Career Qualifications/Achievements - New Business and Market Development, New Product Development, Global and National Sales Team Management, New Product Opportunity Identification, New Product and/or Service Introductions, Competitive and Market Analysis, Product Pricing Strategies, Marketing Data & Analytics Strategy & Measurement, Senior Client Relations, Senior Creative Marketing Strategist and Developer, Creative Developer, and Award Winning Producer/Writer/Digital Campaign Developer. Work Experience: https://www.linkedin.com/in/michael-lefort-4555654b/

**Name**

Karl Thomsen

**Principal occupation and employment responsibilities during at least the last three (3) years with start and ending dates**

| Start Date | End Date | Company | Position / Title |
| --- | --- | --- | --- |
| 06/01/2015 | 10/09/2021 | Optimized Aspects | Chief Executive Officer |
| 10/10/2021 | Present | Infuse | Chief Executive Officer |
| 01/20/2022 | Present | CliqRex Inc. | CTO |

Education: Louisiana State University: Doctorate of Musical Arts (abd) Choral/Orchestral Conducting Yale University: Master's of Arts University of Northern Iowa: Master's of Music Murray State University: Bachelor of Arts in Music/German Trinity University: Metaphysics / Legal Theory Chief Executive Officer - Infuse (Optimized Aspects). A software development company. San Francisco, CA President/Founder - Bridge International. Advertising Agency servicing mostly FemCare for Procter & Gamble. Cincinnati, OH International/Domestic Branch Manager - Bear Stearns Investment Bank. New York, NY. Work Experience: https://www.linkedin.com/in/karl-thomsen-925a0649/

**Name**

James O'Loughlin

**Principal occupation and employment responsibilities during at least the last three (3) years with start and ending dates**

| Start Date | End Date | Company | Position / Title |
| --- | --- | --- | --- |
| 09/01/2020 | Present | Art Academy of Cincinnati | Adjunct Professor |
| 01/01/2018 | 01/01/2020 | University of Cincinnati | Adjunct Professor - DAAP |
| 06/10/2019 | Present | Pixaura Holdings LLC | Manager |
| 01/20/2022 | Present | CliqRex Inc. | Co-Founder and CEO |
| 02/01/2019 | Present | Pixaura Digital | Co-Founder and CEO |

Short Bio: James has always been intrigued by technology and has been at the forefront of utilizing it since a young age. He started programming on Apple in the late 1970s and wrote a grade-keeping program for

his high school teachers at age 14. He joined the Army in 1989 and repaired missile guidance systems. He then set up and ran multi-line bulletin board systems in the early 1990s. Also during this time, while attending Miami University, he set up the university's computer networking system for faculty and students. In the early 2000s, he worked as a developer and created a CMS (content management system) for hundreds of clients. He was promoted to Vice President and helped grow the business into a full-service digital agency. After 20 years there, he started up Pixaura as co-founder and CEO, and has grown the business to 20 employees in 3 years. For the last 5+ years, he has been honing his craft by teaching UI/UX at the University of Cincinnati and The Art Academy of Cincinnati. James was also an early adopter of cryptocurrencies and started mining Bitcoins in 2011. He thought Bitcoin was the most exciting technology he had encountered until he and his wife, Dara, created CliqRex. Outside of technology, James was the president of Team Hungry Cycling, Cincinnati's largest cycling team, for ten years. He has completed multiple 100-mile mountain bike races, triathlons, and what is deemed the most difficult gravel bike race in the country, a 200-mile race across Kansas. The challenge of completing an ultra-endurance race requires training, technology (bike), tools, nutrition, and, most importantly, the perseverance to finish in the face of what sometimes feels like an insurmountable obstacle. James has the drive to see projects, goals, and dreams to completion. Work Experience: https://www.linkedin.com/in/jamesoloughlin/

## Principal Security Holders

5. Provide the name and ownership level of each person, as of the most recent practicable date, who is the beneficial owner of 20 percent or more of the issuer's outstanding voting equity securities, calculated on the basis of voting power. To calculate total voting power, include all securities for which the person directly or indirectly has or shares the voting power, which includes the power to vote or to direct the voting of such securities. If the person has the right to acquire voting power of such securities within 60 days, including through the exercise of any option, warrant or right, the conversion of a security, or other arrangement, or if securities are held by a member of the family, through corporations or partnerships, or otherwise in a manner that would allow a person to direct or control the voting of the securities (or share in such direction or control - as, for example, a co-trustee) they should be included as being "beneficially owned." You should include an explanation of these circumstances in a footnote to the "Number of and Class of Securities Now Held." To calculate outstanding voting equity securities, assume all outstanding options are exercised and all outstanding convertible securities converted.

### James O'Loughlin
(Through Pixaura
Holdings LLC)

| Securities: | 4,125,000 |
| --- | --- |
| Class: | Class A Voting Common Stock |
| Voting Power: | 41.3% |

### Timur Akilov (Through
Pixaura Holdings LLC)

| Securities: | 3,526,875 |
| --- | --- |
| Class: | Class A Voting Common Stock |
| Voting Power: | 35.3% |

# Business and Anticipated Business Plan

## 6. Describe in detail the business of the issuer and the anticipated business plan of the issuer.

Cliqrex is a company that aims to change the way that people communicate their preferences. Micro-Social is the future of social media and Cliqrex is at the forefront of this movement. CliqRex is an app that aims to leverage human affinity and technology to connect the fragmented digital entertainment world. We provide powerful recommendations [Rex] from your most trusted source - your inner circle - your Clique [Cliq]. You can consume all your digital entertainment with just one Click [Cliq] from the app, with your friends never more than a tiny Rex arm's length away! We even help you discover new people with whom you might Click [Cliq] based on your mutual Rex. Additionally, we are acknowledging the negative impact of social media on mental health and society at large; by creating a digital environment that nurtures positive social wellbeing for users, we aim to better the lives of all 'Cliqs.'

CliqRex currently has 8 employees.

## Risk Factors

*A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment.*

*In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document.*

*The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature.*

*These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.*

## 7. Material factors that make an investment in CliqRex Inc. speculative or risky:

1. Pandemic Risks. We face risks related to health epidemics and other outbreaks, which could significantly disrupt the Company's operations and could have a material adverse impact on us. The outbreak of pandemics and epidemics could materially and adversely affect the Company's business, financial condition, and results of operations. If a pandemic occurs in areas in which we have material operations or sales, the Company's business activities originating from affected areas, including sales, materials, and supply chain related activities, could be adversely affected. Disruptive activities could include the temporary closure of facilities used in the Company's supply chain processes, restrictions on the export or shipment of products necessary to run the Company's business, business closures in impacted areas, and restrictions on the Company's employees' or consultants' ability to travel and to meet with customers, vendors or other business relationships. The extent to which a pandemic or other health outbreak impacts the Company's results will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of a virus and the actions to contain it or treat its impact, among others. Pandemics can also result in social, economic, and labor instability which may adversely impact the Company's business. If the Company's employees or employees of any of the Company's vendors, suppliers or customers become ill or are quarantined and in either or both events are therefore unable to work, the Company's

operations could be subject to disruption. The extent to which a pandemic affects the Company's results will depend on future developments that are highly uncertain and cannot be predicted.1. 2. Any valuation at this stage is difficult to assess. Unlike listed companies that are valued publicly through market-driven stock prices, the valuation of private companies, especially startups, is difficult to assess and you may risk overpaying for your investment. In addition, there may be additional classes of equity with rights that are superior to the class of equity being sold.
2. 3. We are highly dependent on the services of our founder. Our future business and results of operations depend in significant part upon the continued contributions of our CEO and founder. If we lose those services or if he fails to perform in his current position, or if we are not able to attract and retain skilled employees in addition to our CEO and the current team, this could adversely affect the development of our business plan and harm our business. In addition, the loss of any other member of the board of directors or executive officers could harm the Company's business, financial condition, cash flow and results of operations.
3. 4. Start-up investing is risky. Investing in early-stage companies is very risky, highly speculative, and should not be made by anyone who cannot afford to lose their entire investment. Unlike an investment in a mature business where there is a track record of revenue and income, the success of a startup or early-stage venture often relies on the development of a new product or service that may or may not find a market. Before investing, you should carefully consider the specific risks and disclosures related to both this offering type and the company.
4. 5. Your shares are not easily transferable. You should not plan on being able to readily transfer and/or resell your security. Currently there is no market or liquidity for these shares and the company does not have any plans to list these shares on an exchange or other secondary market. At some point the company may choose to do so, but until then you should plan to hold your investment for a significant period of time before a 'liquidation event' occurs. A 'liquidation event' is when the company either lists their shares on an exchange, is acquired, or goes bankrupt.
5. 6. Dividends. Unless otherwise specified in the offering documents and subject to state law, you are not entitled to receive any dividends on your interest in the Company. Accordingly, any potential investor who anticipates the need for current dividends or income from an investment should not purchase any of the securities offered on the Site.
6. 7. Operations Risk. The Company's ability to continue operations is dependent upon our ability to generate sufficient cash flows from operations to meet our obligations, and/or to obtain additional capital financing.
7. 8. The Company has the right to extend the Offering deadline. The Company may extend the Offering deadline beyond what is currently stated herein. This means that your investment may continue to be held in escrow while the Company attempts to raise the maximum offering amount even after the Offering deadline stated herein is reached. Your investment will not be accruing interest during this time and will simply be held until such time that Offering is closed, at which time it will be released to the Company to be used as set forth herein. Upon or shortly after release of such funds to the Company, the Securities will be issued and distributed to you.
8. 9. You may only receive limited disclosure. While the Company must disclose certain information, since the Company is at an early-stage they may only be able to provide limited information about its business plan and operations because it does not have fully developed operations or a long history. The Company may also only be obligated to file information periodically regarding its business, including financial statements. A publicly listed company, in contrast, is required to file annual and quarterly reports and promptly disclose certain events - through continuing disclosure that you can use to evaluate the status of your investment.
9. 10. Technological Risk. We operate in an emerging market that is characterized by rapid changes in customer requirements, frequent introductions of new and enhanced products, and continuing and rapid technological advancement. Our technology may underperform the technology utilized by our competitors.
10. 11. No governmental agency has reviewed the Company's offering and no state or federal agency has passed upon either the adequacy of the disclosure contained herein or the fairness of the terms of this offering.

12. *The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature.*

You should not rely on the fact that our Form C, and if applicable Form D is accessible through the U.S. Securities and Exchange Commission's EDGAR filing system as an approval, endorsement or guarantee of compliance as it relates to this Offering.

13. *Neither the Offering nor the Securities have been registered under federal or state securities laws, leading to an absence of certain regulation applicable to the Company.*

The securities being offered have not been registered under the Securities Act of 1933 (the 'Securities Act'), in reliance on exemptive provisions of the Securities Act. Similar reliance has been placed on apparently available exemptions from securities registration or qualification requirements under applicable state securities laws. No assurance can be given that any offering currently qualifies or will continue to qualify under one or more of such exemptive provisions due to, among other things, the adequacy of disclosure and the manner of distribution, the existence of similar offerings in the past or in the future, or a change of any securities law or regulation that has retroactive effect. If, and to the extent that, claims or suits for rescission are brought and successfully concluded for failure to register any offering or other offerings or for acts or omissions constituting offenses under the Securities Act, the Securities Exchange Act of 1934, or applicable state securities laws, the Company could be materially adversely affected, jeopardizing the Company's ability to operate successfully. Furthermore, the human and capital resources of the Company could be adversely affected by the need to defend actions under these laws, even if the Company is ultimately successful in its defense.

14. *The Company has the right to extend the Offering Deadline, conduct multiple closings, or end the Offering early.*

The Company may extend the Offering Deadline beyond what is currently stated herein. This means that your investment may continue to be held in escrow while the Company attempts to raise the Minimum Amount even after the Offering Deadline stated herein is reached. While you have the right to cancel your investment up to 48 hours before an Offering Deadline, if you choose to not cancel your investment, your investment will not be accruing interest during this time and will simply be held until such time as the new Offering Deadline is reached without the Company receiving the Minimum Amount, at which time it will be returned to you without interest or deduction, or the Company receives the Minimum Amount, at which time it will be released to the Company to be used as set forth herein. Upon or shortly after release of such funds to the Company, the Securities will be issued and distributed to you. If the Company reaches the target offering amount prior to the Offering Deadline, they may conduct the first of multiple closings of the Offering prior to the Offering Deadline, provided that the Company gives notice to the investors of the closing at least five business days prior to the closing (absent a material change that would require an extension of the Offering and reconfirmation of the investment commitment). Thereafter, the Company may conduct additional closings until the Offering Deadline. The Company may also end the Offering early; if the Offering reaches its target offering amount after 21-calendar days but before the deadline, the Company can end the Offering with 5 business days' notice. This means your failure to participate in the Offering in a timely manner, may prevent you from being able to participate - it also means the Company may limit the amount of capital it can raise during the Offering by ending it early.

15. *The Company's management may have broad discretion in how the Company uses the net proceeds of the Offering.*

Despite that the Company has agreed to a specific use of the proceeds from the Offering, the Company's management will have considerable discretion over the allocation of proceeds from the

Offering. You may not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately.

16. *The Securities issued by the Company will not be freely tradable until one year from the initial purchase date. Although the Securities may be tradable under federal securities law, state securities regulations may apply, and each Investor should consult with his or her attorney.*

You should be aware of the long-term nature of this investment. There is not now and likely will not be a public market for the Securities. Because the Securities offered in this Offering have not been registered under the Securities Act or under the securities laws of any state or non-United States jurisdiction, the Securities have transfer restrictions and cannot be resold in the United States except pursuant to Rule 501 of Regulation CF. It is not currently contemplated that registration under the Securities Act or other securities laws will be affected. Limitations on the transfer of the shares of Securities may also adversely affect the price that you might be able to obtain for the shares of Securities in a private sale. Investors should be aware of the long-term nature of their investment in the Company. Investors in this Offering will be required to represent that they are purchasing the Securities for their own account, for investment purposes and not with a view to resale or distribution thereof.

17. *Investors will not be entitled to any inspection or information rights other than those required by Regulation CF.*

Investors will not have the right to inspect the books and records of the Company or to receive financial or other information from the Company, other than as required by Regulation CF. Other security holders of the Company may have such rights. Regulation CF requires only the provision of an annual report on Form C and no additional information - there are numerous methods by which the Company can terminate annual report obligations, resulting in no information rights, contractual, statutory or otherwise, owed to Investors. This lack of information could put Investors at a disadvantage in general and with respect to other security holders.

18. *The shares of Securities acquired upon the Offering may be significantly diluted as a consequence of subsequent financings.*

Company equity securities will be subject to dilution. Company intends to issue additional equity to future employees and third-party financing sources in amounts that are uncertain at this time, and as a consequence, holders of Securities will be subject to dilution in an unpredictable amount. Such dilution may reduce the purchaser’s economic interests in the Company.

19. The amount of additional financing needed by Company will depend upon several contingencies not foreseen at the time of this Offering. Each such round of financing (whether from the Company or other investors) is typically intended to provide the Company with enough capital to reach the next major corporate milestone. If the funds are not sufficient, Company may have to raise additional capital at a price unfavorable to the existing investors. The availability of capital is at least partially a function of capital market conditions that are beyond the control of the Company. There can be no assurance that the Company will be able to predict accurately the future capital requirements necessary for success or that additional funds will be available from any source. Failure to obtain such financing on favorable terms could dilute or otherwise severely impair the value of the investor’s Company securities.

20. *There is no present public market for these Securities and we have arbitrarily set the price.*

The offering price was not established in a competitive market. We have arbitrarily set the price of the Securities with reference to the general status of the securities market and other relevant factors. The Offering price for the Securities should not be considered an indication of the actual value of the

Securities and is not based on our net worth or prior earnings. We cannot assure you that the Securities could be resold by you at the Offering price or at any other price.

21. In addition to the risks listed above, businesses are often subject to risks not foreseen or fully appreciated by the management. It is not possible to foresee all risks that may affect us. Moreover, the Company cannot predict whether the Company will successfully effectuate the Company's current business plan. Each prospective Investor is encouraged to carefully analyze the risks and merits of an investment in the Securities and should take into consideration when making such analysis, among other, the Risk Factors discussed above.

22. THE SECURITIES OFFERED INVOLVE A HIGH DEGREE OF RISK AND MAY RESULT IN THE LOSS OF YOUR ENTIRE INVESTMENT. ANY PERSON CONSIDERING THE PURCHASE OF THESE SECURITIES SHOULD BE AWARE OF THESE AND OTHER FACTORS SET FORTH IN THIS OFFERING STATEMENT AND SHOULD CONSULT WITH HIS OR HER LEGAL, TAX AND FINANCIAL ADVISORS PRIOR TO MAKING AN INVESTMENT IN THE SECURITIES. THE SECURITIES SHOULD ONLY BE PURCHASED BY PERSONS WHO CAN AFFORD TO LOSE ALL OF THEIR INVESTMENT.

## The Offering

CliqRex Inc. ("Company") is offering securities under Regulation CF, through Netcapital Funding Portal Inc. ("Portal"). Portal is a FINRA/SEC registered funding portal and will receive cash compensation equal to 4.9% of the value of the securities sold through Regulation CF. Investments made under Regulation CF involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest.

The Company plans to raise between $10,000 and $1,050,000 through an offering under Regulation CF. Specifically, if we reach the target offering amount of $10,000, we may conduct the first of multiple or rolling closings of the offering early if we provide notice about the new offering deadline at least five business days prior to such new offering deadline (absent a material change that would require an extension of the offering and reconfirmation of the investment commitment). Oversubscriptions will be allocated on a first come, first served basis. Changes to the offering, material or otherwise, occurring after a closing, will only impact investments which have yet to be closed.

In the event The Company fails to reach the offering target of $10,000, any investments made under the offering will be cancelled and the investment funds will be returned to the investor.

### 8. What is the purpose of this offering?

Funding: Marketing: Communication Budget; Social Media PPC, Influencers, Referrals Technology: Tech Fees + Product Development Salaries: President and Manager salaries Legal: Legal Fees Accounting: Bookkeeping and Accounting Administrative Expenses: Administrative Expenses

### 9. How does the issuer intend to use the proceeds of this offering?

| Uses | If Target Offering Amount Sold | If Maximum Amount Sold |
| --- | --- | --- |
| Intermediary Fees | $490 | $51,450 |
| Salaries | $0 | $149,783 |
| Marketing | $9,510 | $409,405 |
| Technology & Product Development | $0 | $199,710 |
| Accounting | $0 | $29,956 |
| Administrative | $0 | $109,841 |
| Legal | $0 | $99,855 |
| Total Use of Proceeds | $10,000 | $1,050,000 |

#### 10. How will the issuer complete the transaction and deliver securities to the investors?

In entering into an agreement on the Netcapital Funding Portal to purchase securities, both investors and CliqRex Inc. must agree that a transfer agent, which keeps records of our outstanding Class C Voting Common Stock (the 'Securities'), will issue digital Securities in the investor's name (a paper certificate will not be printed). Similar to other online investment accounts, the transfer agent will give investors access to a web site to see the number of Securities that they own in our company. These Securities will be issued to investors after the deadline date for investing has passed, as long as the targeted offering amount has been reached. The transfer agent will record the issuance when we have received the purchase proceeds from the escrow agent who is holding your investment commitment.

#### 11. How can an investor cancel an investment commitment?

You may cancel an investment commitment for any reason until 48 hours prior to the deadline identified in the offering by logging in to your account with Netcapital, browsing to the Investments screen, and clicking to cancel your investment commitment. Netcapital will notify investors when the target offering amount has been met. If the issuer reaches the target offering amount prior to the deadline identified in the offering materials, it may close the offering early if it provides notice about the new offering deadline at least five business days prior to such new offering deadline (absent a material change that would require an extension of the offering and reconfirmation of the investment commitment). If an investor does not cancel an investment commitment before the 48-hour period prior to the offering deadline, the funds will be released to the issuer upon closing of the offering and the investor will receive securities in exchange for his or her investment. If an investor does not reconfirm his or her investment commitment after a material change is made to the offering, the investor's investment commitment will be cancelled and the committed funds will be returned.

#### 12. Can the Company perform multiple closings or rolling closings for the offering?

If we reach the target offering amount prior to the offering deadline, we may conduct the first of multiple closings of the offering early, if we provide notice about the new offering deadline at least five business days prior (absent a material change that would require an extension of the offering and reconfirmation of the investment commitment). Thereafter, we may conduct additional closings until the offering deadline. We will issue Securities in connection with each closing. Oversubscriptions will be allocated on a first come, first served basis. Changes to the offering, material or otherwise, occurring after a closing, will only impact investments which have yet to be closed.

## Ownership and Capital Structure

## The Offering

13. Describe the terms of the securities being offered.

We are issuing Securities at an offering price of $0.50 per share.

14. Do the securities offered have voting rights?

The Securities are being issued with voting rights. However, so that the crowdfunding community has the opportunity to act together and cast a vote as a group when a voting matter arises, a record owner will cast your vote for you. Please refer to the record owner agreement that you sign before your purchase is complete.

15. Are there any limitations on any voting or other rights identified above?

You are giving your voting rights to the record owner, who will vote the Securities on behalf of all investors who purchased Securities on the Netcapital crowdfunding portal.

16. How may the terms of the securities being offered be modified?

Any provision of the terms of the Securities being offered may be amended, waived or modified by written consent of the majority owner(s) of the Company. We may choose to modify the terms of the Securities before the offering is completed. However, if the terms are modified, and we deem it to be a material change, we need to contact you and you will be given the opportunity to reconfirm your investment. Your reconfirmation must be completed within five business days of receipt of the notice of a material change, and if you do not reconfirm, your investment will be canceled and your money will be returned to you.

## Restrictions on Transfer of the Securities Offered

The securities being offered may not be transferred by any purchaser of such securities during the one-year period beginning when the securities were issued, unless such securities are transferred:

- to the issuer;
- to an accredited investor;
- as part of an offering registered with the U.S. Securities and Exchange Commission; or
- to a member of the family of the purchaser or the equivalent, to a trust controlled by the purchaser, to a trust created for the benefit of a member of the family of the purchaser or the equivalent, or in connection with the death or divorce of the purchaser or other similar circumstance.

The term “accredited investor” means any person who comes within any of the categories set forth in Rule 501(a) of Regulation D, or who the seller reasonably believes comes within any of such categories, at the time of the sale of the securities to that person.

The term “member of the family of the purchaser or the equivalent” includes a child, stepchild, grandchild, parent, stepparent, grandparent, spouse or spousal equivalent, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law of the purchaser, and includes adoptive relationships. The term “spousal equivalent” means a cohabitant occupying a relationship generally equivalent to that of a spouse.

## Description of Issuer’s Securities

17. What other securities or classes of securities of the issuer are outstanding? Describe the material terms of any other outstanding securities or classes of securities of the issuer.

# Securities

| Class of Security | Amount Authorized | Amount Outstanding | Voting Rights | Other Rights |
| --- | --- | --- | --- | --- |
| Class A Voting Common Stock | 10,000,000 | 9,900,000 | Yes | Two votes per share. |
| Class C Voting Common Stock | 2,500,000 | 0 | No | Class C Common Stock has one vote per share. Class C Common Stock is entitled to vote on all matters on which stockholders may vote, except that Class C Common Stock has no right to vote with respect to the election or removal of the Board of Directors. |
| Class B Non-Voting Common Stock | 1,000,000 | 100,000 | No |  |

# Options, Warrants and Other Rights

| Type | Description | Reserved Securities |
| --- | --- | --- |
| Incentive Option Plan | The Company's 2022 Incentive Option Plan (the Plan), which is shareholder approved, permits the grant of share options and shares to its employees, advisors and subcontractors for up to 900,000 shares of the Company's Class B Non-voting Common Stock. As of December 31, 2022, the Company had granted 300,000 options under the Plan with an exercise price of $0.10 per share and 146,000 options with an exercise price of $0.50 per share. The option awards have 10-year contractual terms and vest on varying schedules. At December 31, 2022, none of these shares had vested. | 900,000 |

# **18. How may the rights of the securities being offered be materially limited, diluted or qualified by the rights of any other class of securities?**

The Company's 2022 Incentive Option Plan permits the grant of share options and shares to its employees, advisors and subcontractors for up to 900,000 shares of the Company's Class B Non-voting Common Stock. As of December 31, 2022, the Company had granted 300,000 options under the Plan with an exercise price of $0.10 per share and 146,000 options with an exercise price of $0.50 per share. The option awards have 10-year contractual terms and vest on varying schedules. At December 31, 2022, none of these shares had vested. If any of the options are converted into stock, your shares will be diluted.

# **19. Are there any differences not reflected above between the securities being offered and each other class of security of the issuer?**

The Company has granted a perpetual waiver of the transfer restrictions listed in the bylaws of CliqRex Inc. for all Securities sold in this Offering.

# **20. How could the exercise of rights held by the principal owners identified in Question 5 above affect the purchasers of Securities being offered?**

The Company's bylaws can be amended by the shareholders of the Company, and directors can be added or removed by shareholder vote. As minority owners, you are subject to the decisions made by the majority owners. The issued and outstanding common stock gives management voting control of the Company. As a minority owner, you may be outvoted on issues that impact your investment, such as the issuance of additional shares, or the sale of debt, convertible debt or assets of the Company.

**21. How are the securities being offered being valued? Include examples of methods for how such securities may be valued by the issuer in the future, including during subsequent corporate actions.**

The price of the Securities was determined solely by the management and bears no relation to traditional measures of valuation such as book value or price-to-earnings ratios. We expect that any future valuation will take the same approach.

**22. What are the risks to purchasers of the securities relating to minority ownership in the issuer?**

As the holder of a majority of the voting rights in the company, our majority shareholders may make decisions with which you disagree, or that negatively affect the value of your investment in the company, and you will have no recourse to change those decisions. Your interests may conflict with the interests of other investors, and there is no guarantee that the company will develop in a way that is advantageous to you. For example, the majority shareholders may decide to issue additional shares to new investors, sell convertible debt instruments with beneficial conversion features, or make decisions that affect the tax treatment of the company in ways that may be unfavorable to you. Based on the risks described above, you may lose all or part of your investment in the securities that you purchase, and you may never see positive returns.

**23. What are the risks to purchasers associated with corporate actions including:**

- additional issuances of securities,
- issuer repurchases of securities,
- a sale of the issuer or of assets of the issuer or
- transactions with related parties?

The issuance of additional shares of our common stock will dilute your ownership. As a result, if we achieve profitable operations in the future, our net income per share will be reduced because of dilution, and the market price of our common stock, if there is a market price, could decline as a result of the additional issuances of securities. If we repurchase securities, so that the above risk is mitigated, and there are fewer shares of common stock outstanding, we may not have enough cash available for marketing expenses, growth, or operating expenses to reach our goals. If we do not have enough cash to operate and grow, we anticipate the market price of our stock would decline. A sale of our company or of the assets of our company may result in an entire loss of your investment. We cannot predict the market value of our company or our assets, and the proceeds of a sale may not be cash, but instead, unmarketable securities, or an assumption of liabilities. In addition to the payment of wages and expense reimbursements, we may need to engage in transactions with officers, directors, or affiliates. By acquiring an interest in the Company, you will be deemed to have acknowledged the existence of any such actual or potential related party transactions and waived any claim with respect to any liability arising from a perceived or actual conflict of interest. In some instances, we may deem it necessary to seek a loan from related parties. Such financing may not be available when needed. Even if such financing is available, it may be on terms that are materially averse to your interests with respect to dilution of book value, dividend preferences, liquidation preferences, or other terms. No assurance can be given that such funds will be available or, if available, will be on commercially reasonable terms satisfactory to us. If we are unable to obtain financing on reasonable terms, we could be forced to discontinue our operations. We anticipate that any transactions with related parties will be vetted and approved by executives(s) unaffiliated with the related parties.

**24. Describe the material terms of any indebtedness of the issuer:**

| Creditor(s): | Pixaura Digital LLC |
| --- | --- |
| Amount Outstanding: | $51,839 |
| Interest Rate: | 5.0% |
| Maturity Date: | October 1, 2023 |
| Other Material Terms: | Line of Credit to cover operating expenses and legal fees. |
| Creditor(s): | Pixaura Digital LLC |
| Amount Outstanding: | $5,000 |
| Interest Rate: | 5.0% |
| Maturity Date: | March 1, 2024 |
| Other Material Terms: |  |

**25. What other exempt offerings has CliqRex Inc. conducted within the past three years?**

| Date of Offering: | 03/2022 |
| --- | --- |
| Exemption: | Section 4(a)(2) |
| Securities Offered: | Common Stock |
| Amount Sold: | $100 |
| Use of Proceeds: | Legal Fees. |

**26. Was or is the issuer or any entities controlled by or under common control with the issuer a party to any transaction since the beginning of the issuer's last fiscal year, or any currently proposed transaction, where the amount involved exceeds five percent of the aggregate amount of capital raised by the issuer in reliance on Section 4(a)(6) of the Securities Act during the preceding 12-month period, including the amount the issuer seeks to raise in the current offering, in which any of the following persons had or is to have a direct or indirect material interest:**

1. any director or officer of the issuer;
2. any person who is, as of the most recent practicable date, the beneficial owner of 20 percent or more of the issuer's outstanding voting equity securities, calculated on the basis of voting power;
3. if the issuer was incorporated or organized within the past three years, any promoter of the issuer; or
4. any immediate family member of any of the foregoing persons.

Yes.

If yes, for each such transaction, disclose the following:

| Specified Person | Relationship to Issuer | Nature of Interest in Transaction | Amount of Interest |
| --- | --- | --- | --- |
| Pixuara Digital LLC | James O'Loughlin, CliqRex's CEO, and Alpha Citadel Ventures LLC (owned by CliqRex Inc.'s CFO, Timur Akilov) are majority members of Pixaura Digital LLC. | Loan | $56,839 |

## Financial Condition of the Issuer

**27. Does the issuer have an operating history?**

Yes.

# **28. Describe the financial condition of the issuer, including, to the extent material, liquidity, capital resources and historical results of operations.**

CliqRex Inc. (the Company) is a corporation formed on 01/20/2022 under the laws of Delaware. The Company is a micro-social tool for sharing TV shows, movies, books, YouTube videos, and podcasts (other media and products to be added in the future) that are powered through affinity, trust, and shared interests. The Company is currently in its pre-revenue stage. Since inception through December 31, 2022, the Company had $184,963 in operating expenses. Additionally, the Company recorded interest expense of $1,839, resulting in a net loss of $186,802. The Company has funded operations through a revolving credit line with a related party, Pixaura Digital LLC. As of December 31, 2022, the Company had drawn $51,839, including accrued interest, on the credit line. The Company is currently raising money through a Regulation Crowdfunding Offering with Netcapital. As of December 31, 2022, the Company raised gross proceeds of $87,346 in exchange for 174,694 Class C Shares. On February 28, 2023 the Company opened a revolving line of credit note with Pixaura Digital LLC (a related party) that allows the Company to draw up to $30,000 in principal. As of March 31, 2023, the Company had drawn $5,000 from the credit line. The note carries an interest rate of 5% and all amounts outstanding, including accrued interest, are due and payable on March 1, 2024. With this raise, the Company plans to use the proceeds primarily for salaries, marketing, product development, and legal fees.

## Financial Information

# **29. Include the financial information specified by regulation, covering the two most recently completed fiscal years or the period(s) since inception if shorter.**

See attachments:

CPA Review Report: reviewletter.pdf

30. With respect to the issuer, any predecessor of the issuer, any affiliated issuer, any director, officer, general partner or managing member of the issuer, any beneficial owner of 20 percent or more of the issuer's outstanding voting equity securities, calculated in the same form as described in Question 6 of this Question and Answer format, any promoter connected with the issuer in any capacity at the time of such sale, any person that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with such sale of securities, or any general partner, director, officer or managing member of any such solicitor, prior to May 16, 2016:

1. Has any such person been convicted, within 10 years (or five years, in the case of issuers, their predecessors and affiliated issuers) before the filing of this offering statement, of any felony or misdemeanor:
1. in connection with the purchase or sale of any security?
2. involving the making of any false filing with the Commission?
3. arising out of the conduct of the business of an underwriter, broker, dealer, municipal securities dealer, investment adviser, funding portal or paid solicitor of purchasers of securities?

2. Is any such person subject to any order, judgment or decree of any court of competent jurisdiction, entered within five years before the filing of the information required by Section 4A(b) of the Securities Act that, at the time of filing of this offering statement, restrains or enjoins such person from engaging or continuing to engage in any conduct or practice:
1. in connection with the purchase or sale of any security?;
2. involving the making of any false filing with the Commission?
3. arising out of the conduct of the business of an underwriter, broker, dealer, municipal securities dealer, investment adviser, funding portal or paid solicitor of purchasers of securities?

3. Is any such person subject to a final order of a state securities commission (or an agency or officer of a state performing like functions); a state authority that supervises or examines banks, savings associations or credit unions; a state insurance commission (or an agency or officer of a state performing like functions); an appropriate federal banking agency; the U.S. Commodity Futures Trading Commission; or the National Credit Union Administration that:
1. at the time of the filing of this offering statement bars the person from:
1. association with an entity regulated by such commission, authority, agency or officer?
2. engaging in the business of securities, insurance or banking?
3. engaging in savings association or credit union activities?

2. constitutes a final order based on a violation of any law or regulation that prohibits fraudulent, manipulative or deceptive conduct and for which the order was entered within the 10-year period ending on the date of the filing of this offering statement?

4. Is any such person subject to an order of the Commission entered pursuant to Section 15(b) or 15B(c) of the Exchange Act or Section 203(e) or (f) of the Investment Advisers Act of 1940 that, at the time of the filing of this offering statement:
1. suspends or revokes such person's registration as a broker, dealer, municipal securities dealer, investment adviser or funding portal?
2. places limitations on the activities, functions or operations of such person?
3. bars such person from being associated with any entity or from participating in the offering of any penny stock?

If Yes to any of the above, explain:

5. Is any such person subject to any order of the Commission entered within five years before the filing of this offering statement that, at the time of the filing of this offering statement, orders the person to cease and desist from committing or causing a violation or future violation of:

1. any scienter-based anti-fraud provision of the federal securities laws, including without limitation Section 17(a)(1) of the Securities Act, Section 10(b) of the Exchange Act, Section 15(c)(1) of the Exchange Act and Section 206(1) of the Investment Advisers Act of 1940 or any other rule or regulation thereunder?
2. Section 5 of the Securities Act?
6. Is any such person suspended or expelled from membership in, or suspended or barred from association with a member of, a registered national securities exchange or a registered national or affiliated securities association for any act or omission to act constituting conduct inconsistent with just and equitable principles of trade?
7. Has any such person filed (as a registrant or issuer), or was any such person or was any such person named as an underwriter in, any registration statement or Regulation A offering statement filed with the Commission that, within five years before the filing of this offering statement, was the subject of a refusal order, stop order, or order suspending the Regulation A exemption, or is any such person, at the time of such filing, the subject of an investigation or proceeding to determine whether a stop order or suspension order should be issued?
8. Is any such person subject to a United States Postal Service false representation order entered within five years before the filing of the information required by Section 4A(b) of the Securities Act, or is any such person, at the time of filing of this offering statement, subject to a temporary restraining order or preliminary injunction with respect to conduct alleged by the United States Postal Service to constitute a scheme or device for obtaining money or property through the mail by means of false representations?

CliqRex Inc. needs to certify.

## Other Material Information

31. In addition to the information expressly required to be included in this Form, include: any other material information presented to investors; and such further material information, if any, as may be necessary to make the required statements, in the light of the circumstances under which they are made, not misleading.

The following is a transcript of the first video shown on this Company's Offering: You're finally done running around and figuring things out for the day and at last it's time to relax and watch a show. You sit down on your couch, turn on your tv and then end up feeling overwhelmed by all the choices. You don't know what's good or what network to look on, don't remember what show your friend told you about and are saddled with having to figure out what to watch when you just want to relax. It's no wonder that what to watch was the number one google search question in 2021 but we've got you - we made a way that you can connect directly with what your friends are loving. We made a special app where you can see how your friends' read shows and read what they thought about them. You can save what you watch, see what network the shows are on, share your own favorites, and keep it all organized in one place. If you're like us you'll find it's much more rewarding when you trust the recommendations of a friend than when you're left guessing from a list of suggestions made by a computer. You'll be able to share in your excitement and discover whose taste you align with the most. We've found CliqRex to be a place to come back to again and again to get more recommendations or rex from your friends or click, and CliqRex is not just for recommendations of shows but also movies and podcasts to start. CliqRex has the potential for expansion into books music and much more remember when amazon was just for books? Yeah, like that Join us in bringing people-powered recommendations to the world by investing early public shares are now available on Netcapital The following is a transcript of the third video shown on this Company's Offering: Hi, I'm here to share a new app called CliqRex. Have you ever been overwhelmed by the chaos of what to watch or listen to? Cliqrex helps you navigate the confusion by showing you what your trusted friends recommend, instead of what a bot decides. I have a track record of predicting tech trends and creating solutions to

monetize them. 20 years ago, my websites were at the top of Google search results - and I built a business around SEO. Over a decade ago I was mining bitcoins, and now, I'm excited to share our patent pending technology with the world. I am ready for any challenge; like finishing a 200-mile bike race or working hard to enhance the life of my special needs son. My perseverance yields success... Thanks for listening. I hope you invest in CliqRex and our talented team.

The following documents are being submitted as part of this offering:

**Governance:**

**Certificate of Incorporation:** certificateofincorporation.pdf

**Corporate Bylaws:** corporatebylaws.pdf

**Opportunity:**

**Offering Page JPG:** offeringpage.jpg

**Financials:**

**Additional Information:** otherfinancial.pdf

## Ongoing Reporting

**32. The issuer will file a report electronically with the Securities & Exchange Commission annually and post the report on its web site, no later than 120 days after the end of each fiscal year covered by the report:**

Once posted, the annual report may be found on the issuer's web site at: https://cliqrex.com

The issuer must continue to comply with the ongoing reporting requirements until:

- the issuer is required to file reports under Section 13(a) or Section 15(d) of the Exchange Act;
- the issuer has filed at least one annual report pursuant to Regulation Crowdfunding and has fewer than 300 holders of record and has total assets that do not exceed $10,000,000;
- the issuer has filed at least three annual reports pursuant to Regulation Crowdfunding;
- the issuer or another party repurchases all of the securities issued in reliance on Section 4(a)(6) of the Securities Act, including any payment in full of debt securities or any complete redemption of redeemable securities; or
- the issuer liquidates or dissolves its business in accordance with state law.

**Attachment 2:** `reviewletter.pdf`

# CliqRex Inc.

## Financial Statements and Report

December 31, 2022

## Table of Contents

| Independent Accountant's Review Report | 2 |
| --- | --- |
| Balance Sheet | 4 |
| Statement of Income | 5 |
| Statement of Cash Flows | 7 |
| Notes to the Financial Statements | 8 |

![img-0.jpeg](img-0.jpeg)

TESSERACT
ADVISORY
GROUP

# Independent Accountant's Review Report

To Management of:
CliqRex Inc.

We have reviewed the accompanying financial statements (financial statements) of CliqRex Inc. (the company), which comprise the balance sheet as of December 31, 2022, and the related statements of income, changes in stockholders' equity, and cash flows for the year then ended, and the related notes to the financial statements. A review includes primarily applying analytical procedures to management's financial data and making inquiries of the company's management. A review is substantially less in scope than an audit, the objective of which is the expression of an opinion regarding the financial statements as a whole. Accordingly, we do not express such an opinion.

# Management's Responsibility for the Financial Statements

Management is responsible for the preparation and fair presentation of these financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement whether due to fraud or error.

# Accountant's Responsibility

Our responsibility is to conduct the review engagement in accordance with Statements on Standards for Accounting and Review Services promulgated by the Accounting and Review Services Committee of the AICPA. Those standards require us to perform procedures to obtain limited assurance as a basis for reporting whether we are aware of any material modifications that should be made to the financial statements

2

for them to be in accordance with accounting principles generally accepted in the United States of America. We believe that the results of our procedures provide a reasonable basis for our conclusion.

*We are required to be independent of CliqRex Inc. (the Company) and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements related to our reviews.*

### **Accountant's Conclusion**

Based on our review, we are not aware of any material modifications that should be made to the accompanying financial statements in order for them to be in accordance with accounting principles generally accepted in the United States of America.

### **Substantial Doubt About the Company's Ability to Continue as a Going Concern**

The accompanying financial statements have been prepared assuming that the company will continue as a going concern. As discussed in Note 6 to the financial statements, the company is pre-revenue and has relied on debt financing from related parties to fund operations, and has stated that substantial doubt exists about the company's ability to continue as a going concern. Management's evaluation of the events and conditions and management's plans regarding these matters are also described in Note 6. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our conclusion is not modified with respect to this matter.

Tesseract Advisory Group, LLC
OWINGS MILLS, MD
March 24, 2023

3

# **CliqRex Inc.**  
 Balance Sheet (Unaudited)  
 As of December 31, 2022

|  | Note |  |
| --- | --- | --- |
| Assets |  |  |
| Current Assets |  |  |
| Cash and cash equivalents | 1.d | $3,449 |
| Total Assets |  | 3,449 |
| Liabilities & Stockholders' Equity |  |  |
| Liabilities |  |  |
| Current Liabilities |  |  |
| Accounts payable and accrued liabilities |  | 965 |
| Total Current Liabilities |  | 965 |
| Related party debt | 3 | 51,839 |
| Total Liabilities |  | 52,804 |
| Stockholders' Equity | 2 |  |
| Common stock, 13,500,000 shares authorized; 10,174,694 shares issued and outstanding; 0.00001 par value per share |  | 101 |
| Additional paid-in capital |  | 137,346 |
| Retained Earnings (Accumulated Deficit) |  | (186,802) |
| Total Stockholders' Equity |  | (49,355) |
| Total Liabilities & Stockholders' Equity |  | $3,449 |

4

See independent accountant's review report. The accompanying notes are an integral part of these financial statements.

# **CliqRex Inc.**  
Statement of Income (Unaudited)  
For the year ended December 31, 2022

| Operating Expenses |  |
| --- | --- |
| Legal and other professional fees and services | $83,131 |
| Share based compensation | 50,000 |
| Salaries and wages | 35,044 |
| Commissions and fees | 12,080 |
| Other expenses | 4,708 |
| Total Operating Expenses | 184,963 |
| Operating Income (Loss) | (184,963) |
| Interest expense | (1,839) |
| Net Income (Loss) | $(186,802) |

5

See independent accountant's review report. The accompanying notes are an integral part of these financial statements.

# **CliqRex Inc.**  
 Statement of Changes in Stockholders' Equity  
 For the year ended December 31, 2022

|  | Class A Shares | Class B Shares | Class C Shares | Common Stock Amount $ | Additional Paid-In Capital $ | Retained Earnings (Accumulated Deficit) $ | Total Stockholders' Equity $ |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Balance at January 20, 2022 | - | - | - | $ - | $ - | $ - | $ - |
| Net income (loss) | - | - | - | - | - | (186,802) | (186,802) |
| Capital contributions | - | - | - | - | 87,346 | - | 87,346 |
| Stock-based compensation expense | 100,000 | - | - | - | 50,000 | - | 50,000 |
| Issuance of common stock | 9,800,000 | 100,000 | 174,694 | 101 | - | - | 101 |
| Total | 9,900,000 | 100,000 | 174,694 | $101 | $137,346 | $(186,802) | $(49,355) |

6

See independent accountant's review report. The accompanying notes are an integral part of these financial statements.

# **CliqRex Inc.**  
 Statement of Cash Flows (Unaudited)  
 For the year ended December 31, 2022

# **Cash Flows**

| Cash Flows From Operating Activities |  |
| --- | --- |
| Net (loss) | $(186,802) |
| Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by (Used in) Operating Activities |  |
| Share based compensation | 50,000 |
| Increase (decrease) in operating liabilities, net of effects of businesses acquired |  |
| Accounts payable and accrued liabilities | 965 |
| Net Cash (Used in) Operating Activities | (135,837) |
| Cash Flows from Financing Activities |  |
| Proceeds from issuance of related party debt | 51,839 |
| Proceeds from issuance of common stock | 101 |
| Capital contributions from owners | 87,346 |
| Net Cash Provided by Financing Activities | 139,286 |
| Net Increase in Cash and Cash Equivalents | 3,449 |
| Cash and cash equivalents at beginning of year | - |
| Cash and Cash Equivalents at End of Year | 3,449 |

# **Supplemental Cash Flow Information**

| Cash Paid During the Year for |  |
| --- | --- |
| Interest | $1,839 |

7

See independent accountant's review report. The accompanying notes are an integral part of these financial statements.

# Notes to the Financial Statements

# **CliqRex Inc.**  
Notes to the Financial Statements  
For the year ended December 31, 2022

# **1. Summary of significant accounting policies**

# **a. Nature of operations**

CliqRex Inc. (the Company) is a Delaware Public Benefit Corp and a micro-social tool for sharing TV shows, movies, books and podcasts (other media and products to be added in the future) that are powered through affinity, trust, and shared interests. The tool allows users to see and store recommendations from their community.

# **b. Basis of accounting**

The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ('GAAP') as detailed in the Financial Accounting Standards Board's Accounting Standards Codification. These financial statements cover the period from the Company's incorporation on January 20, 2022 through December 31, 2022.

# **c. Use of estimates**

The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates.

# **d. Cash and cash equivalents**

Cash and cash equivalents includes short-term investments and highly liquid investments in money market instruments which are carried at the lower of cost and market value with a maturity date of three months or less from the acquisition date. These are valued at cost which approximates market value. The Company's cash consists of deposits held in a commercial checking accounts with a major financial institution.

# **e. Fair value measurements**

Generally accepted accounting principles define fair value as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants at the

8

See independent accountant's review report. The accompanying notes are an integral part of these financial statements.

# **CliqRex Inc.**
Notes to the Financial Statements
For the year ended December 31, 2022

measurement date (exit price) and such principles also establish a fair value hierarchy that prioritizes the inputs used to measure fair value using the following definitions (from highest to lowest priority):

- Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
- Level 2 - Observable inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data by correlation or other means.
- Level 3 - Prices or valuation techniques requiring inputs that are both significant to the fair value measurement and unobservable.

The fair values of assets approximate their carrying value due to the relatively short periods to maturity.

**f. Income taxes**

The Company applies ASC 740 Income Taxes (“ASC 740”). Deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial statement reported amounts at each period end, based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The provision for income taxes represents the tax expense for the period, if any and the change during the period in deferred tax assets and liabilities. ASC 740 also provides criteria for the recognition, measurement, presentation and disclosure of uncertain tax positions. A tax benefit from an uncertain position is recognized only if it is “more likely than not” that the position is sustainable upon examination by the relevant taxing authority based on its technical merit. The Company is subject to tax filing requirements as a corporation in the federal jurisdiction of the United States.

The Company uses a calendar year end for income tax reporting purposes and files a Corporate tax return annually. The Company’s provision for income taxes is based on the asset and liability method of accounting whereby deferred tax assets and liabilities are recognized for future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted

9

See independent accountant’s review report. The accompanying notes are an integral part of these financial statements.

# **CliqRex Inc.**

# **Notes to the Financial Statements**

For the year ended December 31, 2022

tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Deferred tax assets and liabilities are related to differences in calculating depreciation on fixed assets, timing of deductions for certain accrued expenses, and taxes related to net operating losses.

The Company files tax returns in the United States federal jurisdiction and is subject to franchise and income tax filing requirements in the State of Delaware.

# **g. Comprehensive income**

The Company does not have any comprehensive income items other then net income.

# **2. Stockholders' equity**

Under the articles of incorporation, the total number of Common Shares of stock that the Company shall have authority to issue is 13,500,000 shares with a $0.00001 par value per share.

The Common stock is divided into three series:

Class A voting stock of which there are 10,000,000 shares authorized.

Class B non-voting stock of which there are 1,000,000 shares authorized.

Class C voting stock of which there are 2,500,000 shares authorized.

As of December 31, 2022 the total number Class A Common Shares issued and outstanding was 9,900,000, and the total number of Class B Common Shares issued and outstanding was 100,000, and the total number of Class C Common Shares issued and outstanding was 174,694.

# **3. Debt**

On January 21, 2022 the Company opened a revolving line of credit note with Pixaura Digital LLC (a related party) that allows the Company to draw up to $10,000 in principal per month for a maximum amount of $50,000 and carries an interest rate of 5%. The note was amended on September 30, 2022 to extend the due date and all amounts outstanding, including accrued interest, are due and payable on October 1, 2023. As of December 31, 2022, the Company had drawn $51,839, including accrued interest, on the credit line which has been classified as current debt.

10

See independent accountant's review report. The accompanying notes are an integral part of these financial statements.

# **CliqRex Inc.**

# Notes to the Financial Statements  
For the year ended December 31, 2022

# **4. Related party transactions**

Pixaura Digital LLC, a Delaware LLC, provides App development services to CliqRex Inc. and has provided a $50,000 line of credit to the Company. James O'Loughlin, CliqRex's CEO, and Alpha Citadel Ventures LLC (owned by CliqRex Inc.'s CFO, Timur Akilov) are majority members of Pixaura Digital LLC.

Optimized Aspects, LLC (DBA 'Infuse'), an Ohio LLC, whose CEO is the CTO of Cliqrex, Inc., provided app development services to the Company. On October 7, 2022 Optimized Aspects, LLC (DBA 'Infuse') forfeited its stock options for 175,000 shares and no longer provides any services to the Company.

Rethink Lab LLC, an Ohio LLC, provides user experience and wellbeing strategy services to the Company. Gillian W. Oakenfull, CSIO of CliqRex Inc., is the owner of Rethink Lab LLC.

CliqRex Inc. CPO and shareholder Robert J. Roman II in 2022 received compensation in stock (100,000 shares of Class A, at $0.50 per share valuation).

# **5. Equity incentive plans**

The Company's 2022 Incentive Option Plan (the Plan), which is shareholder approved, permits the grant of share options and shares to its employees, advisors and subcontractors for up to 900,000 shares of the Company's Class B Non-voting Common Stock. The Company is authorized to issue the options under this Plan as either Incentive Stock Options or Non-qualified Stock Options as defined by the Internal Revenue Code. As of December 31, 2022, the Company has issued 446,000 shares under the plan with an exercise price of $0.10 per share for 300,000 options and $0.50 per share for 146,000 options. The option awards have 10-year contractual terms and vest on varying schedules. At December 31, 2022, none of these shares had vested.

A summary of Share-based Compensation Arrangements is provided below:

11

See independent accountant's review report. The accompanying notes are an integral part of these financial statements.

# **CliqRex Inc.**

# Notes to the Financial Statements  
For the year ended December 31, 2022

|  | December 31, 2022 |
| --- | --- |
| Beginning shares granted | - |
| Granted during the period | 446,000 |
| Vested | - |
| Total Cumulative Shares Granted for Compensation | 446,000 |
| Ending Balance of Shares Remaining to Vest | 446,000 |

# **6. Commitments and contingencies**

The Company is not currently involved with and does not know of any pending or threatening litigation against the Company.

# **7. Going concern**

These financial statements have been prepared on a going concern basis which contemplates the realization of assets and the payment of liabilities in the ordinary course of business. As shown in the accompanying financial statements, during the year ended December 31, 2022 the Company incurred a loss of $186,802. The Company is pre-revenue and has relied on financing from related parties to fund operations. Those factors and conditions create a substantial doubt about the Company's ability to continue as a going concern for the year following the date the financial statements are available to be issued. Management of the Company has evaluated these conditions and has proposed a plan to raise capital via a crowdfunding campaign. The ability of the Company to continue as a going concern and meet its obligations as they become due is dependent on management's ability to successfully implement the plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

# **8. Subsequent events**

On February 28, 2023 the Company opened a revolving line of credit note with Pixaura Digital LLC (a related party) that allows the Company to draw up to $30,000 in principal. The note carries an interest rate of 5% and all amounts outstanding, including accrued interest, are due and payable on March 1, 2024.

Management evaluated all activity of the Company through March 24, 2023 (the issuance date of the financial statements) and concluded that no other subsequent events have occurred that would require recognition in the financial statements or disclosure in the related notes to the financial statements.

12

See independent accountant's review report. The accompanying notes are an integral part of these financial statements.

**Attachment 3:** `certificateofincorporation.pdf`

State of Delaware
Secretary of State
Division of Corporations
Delivered 06:35 PM 06/06/2022
FILED 06:35 PM 06/06/2022
SR 20222634979 - File Number 6563752

# STATE OF DELAWARE
AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION OF
CLIQREX INC.
A PUBLIC BENEFIT CORPORATION

CliqRex Inc. (the "Corporation"), a public benefit corporation organized and existing under the General Corporation Law of the State of Delaware (the "GCL"), does hereby certify as follows:

1. The name of the Corporation is CliqRex Inc. The Corporation was originally incorporated pursuant to the GCL on January 20, 2022.
2. This Amended and Restated Certificate of Incorporation was duly adopted by the Board of Directors of the Corporation and by the stockholders of the Corporation in accordance with Sections 242 and 245 of the GCL.
3. This Amended and Restated Certificate of Incorporation restates and integrates and further amends the certificate of incorporation of the Corporation.
4. The text of the certificate of incorporation is amended and restated in its entirety as follows:

FIRST: The name of the Corporation is CliqRex Inc.

SECOND: The Corporation's registered office in the State of Delaware is at 1013 Centre Road, Suite 403-B, in the City of Wilmington, County of New Castle, 19805. The name of its registered agent at that address is VCorp Service LLC.

THIRD: The specific public benefit purpose of the Corporation is to provide support to vulnerable communities by way of donations and engagement with community based organizations. In addition, the Corporation may engage in any lawful act or activity for which corporations may be organized under the GCL.

FOURTH: A. Authorized Capital Stock. The total number of shares of stock which the Corporation shall have the authority to issue is 13,500,000 shares of common stock with a par value of $0.00001 per share (the "Common Stock"), which may be issued in three series: (i) 10,000,000 shares of Class A voting common stock ("Class A Voting Common Stock"), (ii) 1,000,000 shares of Class B non-voting common stock ("Class B Non-Voting Common Stock"), and 2,500,000 shares of Class C voting common stock (the "Class C Voting Common Stock" and, together with the Class A Voting Common Stock, the "Voting Common Stock"). The number of authorized shares of Common Stock may be increased or decreased (but not below the number of shares of Common Stock then outstanding) by such affirmative vote of the votes

1

entitled to be cast thereon as may be required at that time by the GCL.

B. Class A Voting Common Stock, Class B Non-Voting Common Stock and Class C Voting Common Stock.

(i) Ranking. The preferences, limitations and rights of the Class A Voting Common Stock, the Class B Non-Voting Common Stock and the Class C Voting Common Stock, and the qualifications and restrictions thereof, shall be in all respects identical, except as otherwise required by law or expressly provided in this Amended and Restated Certificate of Incorporation.

(ii) Voting. Except as otherwise required by law or in this Amended and Restated Certificate of Incorporation (as it may be hereafter be amended), with respect to all matters upon which stockholders are entitled to vote or to which stockholders are entitled to give consent, the holders of any outstanding shares of the (i) Class A Voting Common Stock shall vote together as a single class with the holders of the Class C Voting Common Stock (but, with respect to the Class C Voting Common Stock, only in respect of matters on which Class C Common Stock can vote), and every holder of the Class A Voting Common Stock shall be entitled to cast thereon two (2) votes in person or by proxy for each share of the Class A Voting Common Stock standing in such holder's name, and (ii) Class C Voting Common Stock shall vote together as a single class with the holders of the Class A Voting Common Stock (only in respect of matters on which Class C Common Stock can vote), and every holder of the Class C Voting Common Stock shall be entitled to cast thereon one (1) vote in person or by proxy for each share of the Class C Voting Common Stock standing in such holder's name, provided that while the holders of Class C Voting Common Stock shall generally be entitled to vote on all matters on which stockholders may vote under the GCL, holders of Class C Voting Common Stock shall have no right to vote with respect to the election of directors of the Corporation, their removal as members of the Board of Directors of the Corporation (the "Board of Directors") or the size of the Board of Directors. Except as otherwise required by law or in this Amended and Restated Certificate of Incorporation (as it may be hereafter be amended), the holders of the outstanding shares of Class B Non-Voting Common Stock shall not be entitled to vote on any matter, including any amendment to this Amended and Restated Certificate of Incorporation.

(iii) Amendments Affecting Stock. So long as any shares of Class B Non-Voting Common Stock are outstanding, the Corporation shall not, without such affirmative vote of the votes entitled to be cast on the amendment by the holders of outstanding shares of Class B Non-Voting Common Stock voting as a single class as may be required at that time by the GCL (i) amend, alter or repeal any provision of this Section B of this Article FOURTH so as to affect adversely the relative rights, preferences, qualifications, limitations or restrictions of the Class B Non-Voting Common Stock as compared to those of the Voting Common Stock, or (ii) take any

2

other action upon which class voting of the Class B Non-Voting Common Stock is required by law.

(iv) Dividends; Changes in Stock. No dividend or distribution may be declared or paid on any share of Class A Voting Common Stock unless a dividend or distribution, payable in the same consideration and manner, is simultaneously declared or paid, as the case may be, on each share of Class C Voting Common Stock, and no dividend or distribution may be declared or paid on any share of Voting Common Stock unless a dividend or distribution payable in the same consideration and manner, is simultaneously declared or paid, as the case may be, on each share of Class B Non-Voting Common Stock, nor shall any dividend or distribution be declared or paid on any share of Class C Voting Common Stock unless a dividend or distribution, payable in the same consideration and manner, is simultaneously declared or paid, as the case may be, on each share of Class A Voting Common Stock, nor shall any dividend or distribution be declared or paid on any share of Class B Non-Voting Common Stock unless a dividend or distribution, payable in the same consideration and manner, is simultaneously declared or paid, as the case may be, on each share of Voting Common Stock, in each case without preference or priority of any kind; provided, however, that if dividends are declared that are payable in shares of Class A Voting Common Stock, Class B Non-Voting Common Stock or in Class C Voting Common Stock, or in rights, options, warrants or other securities convertible into or exchangeable for shares of Class A Voting Common Stock, Class B Non-Voting Common Stock, or Class C Voting Common Stock, dividends shall be declared that are payable at the same rate on each series of Common Stock and dividends payable in shares of Class A Voting Common Stock or in rights, options, warrants or other securities convertible into or exchangeable for shares of Class A Voting Common Stock shall be payable to holders of Class A Voting Common Stock, dividends payable in shares of Class B Non-Voting Common Stock or in rights, options, warrants or other securities convertible into or exchangeable for shares of Class B Non-Voting Common Stock shall be payable to holders of Class B Non-Voting Common Stock, and dividends payable in shares of Class C Voting Common Stock or in rights, options, warrants or other securities convertible into or exchangeable for shares of Class C Voting Common Stock shall be payable to holders of Class C Voting Common Stock. If the Corporation in any manner subdivides or combines the outstanding shares of a class of Common Stock, the outstanding shares of such class of Common Stock shall be proportionately subdivided or combined, as the case may be.

(v) Liquidation. Each series of Common Stock shall rank pari passu with shares of each other series of Common Stock as to distribution of assets in the event of any liquidation, dissolution or winding up of the affairs of the Corporation.

(vi) Merger or Consolidation. In the event of a merger or consolidation of the Corporation with or into another entity (whether or not the Corporation is the

3

surviving entity), the holders of each share of Class A Voting Common Stock, Class B Non-Voting Common Stock and Class C Voting Common Stock shall be entitled to receive the same per share consideration as the per share consideration, if any, received by the holders of each share of such other series of Common Stock.

# C. Drag-Along Rights.

(i) Definitions. A “Sale of the Corporation” shall mean either: (a) a transaction, or series of related transactions, in which a Person, or a group of related Persons, acquires from stockholders of the Corporation shares representing more than fifty percent (50%) of the Class A Voting Common Stock (a “Stock Sale”); (b) a transaction in which the Corporation sells, conveys, leases, exclusively licenses or otherwise disposes of all or substantially all of its assets, property or business, except where such sale, conveyance, exclusive license or other disposition is to a wholly-owned subsidiary of the Corporation; or (c) a transaction where the Corporation merges with or into or consolidates with any other corporation, limited liability company or other entity (other than a wholly-owned subsidiary of the Corporation; provided, however that none of the following shall be considered a Sale of the Corporation: (A) a transaction effected exclusively for the purpose of changing the domicile of the Corporation, or creating a holding company that will be owned in substantially the same proportions by the persons who held the Corporation’s securities immediately prior to such transaction; or (B) a transaction in which the stockholders of the Corporation immediately prior to the transaction have sufficient rights (by law or contract) to elect or designate 50% or more of the directors of the surviving or acquiring entity following the transaction (as appropriately adjusted for any disparate director voting rights).

“Person” means any natural person, corporation (stock or non-stock), limited liability company, limited partnership, general partnership, limited liability partnership, joint stock company, joint venture, association (profit or nonprofit), company, estate, trust, bank or other organization, whether or not a legal entity, and any government agency or political subdivision thereof.

(ii) Actions to be Taken. In the event that (i) the Board of Directors, and (ii) the holders of a majority of the then outstanding shares of Class A Voting Common Stock approve a Sale of the Corporation in writing, specifying that this Article FOURTH.C. shall apply to such transaction (with the holders of Class A Voting Common Stock selling such stock in the Sale of the Corporation being “Selling Stockholders”), then each holder of Common Stock (a “Common Holder”) hereby agrees:

(a) if such transaction requires stockholder approval, with respect to all Common Stock that such Common Holder owns or over which such Common Holder otherwise exercises voting power (“Common Shares”), to vote (in person, by proxy or by action by written consent, as applicable) all Common Shares in favor of, and adopt, such Sale of the Corporation (together with any related amendment to this Amended and Restated Certificate of Incorporation required in order to implement

4

such Sale of the Corporation) and to vote in opposition to any and all other proposals that could reasonably be expected to delay or impair the ability of the Corporation to consummate such Sale of the Corporation;

(b) if such transaction is a Stock Sale, to sell the same proportion of shares of capital stock of the Corporation beneficially held by such Common Holder as is being sold by the Selling Stockholders to the person or entity to whom the Selling Stockholders propose to sell their Class A Voting Common Stock, and, except as permitted in clause (iii) directly below, on the same terms and conditions as the Selling Stockholders;

(c) to execute and deliver all related documentation and take such other action in support of the Sale of the Corporation as shall reasonably be requested by the Corporation or the Selling Stockholders in order to carry out the terms and provision of this Article FOURTH.C, including without limitation executing and delivering instruments of conveyance and transfer, and any purchase agreement, merger agreement, indemnity agreement, escrow agreement, consent, waiver, governmental filing, share certificates duly endorsed for transfer (free and clear of impermissible liens, claims and encumbrances) and any similar or related documents;

(d) not to deposit, except as permitted by this Article FOURTH.C, any Common Shares owned by such party in a voting trust or subject any Common Shares to any arrangement or agreement with respect to the voting of such Common Shares, unless specifically requested to do so by the acquirer in connection with the Sale of the Corporation;

(e) to refrain from exercising any dissenters' rights or rights of appraisal under applicable law at any time with respect to such Sale of the Corporation; and

(f) if the consideration to be paid in exchange for the Common Shares pursuant to this Article FOURTH.C includes any securities and due receipt thereof by any Common Holder would require under applicable law (x) the registration or qualification of such securities or of any person as a broker or dealer or agent with respect to such securities or (y) the provision to any Common Holder of any information other than such information as a prudent issuer would generally furnish in an offering made solely to 'accredited investors' as defined in Regulation D promulgated under the Securities Act of 1933, as amended (the 'Securities Act'), the Corporation may cause to be paid to any such Common Holder in lieu thereof, against surrender of the Common Shares which would have otherwise been sold by such Common Holder, an amount in cash equal to the fair value (as determined in good faith by the Corporation) of the securities which such Common Holder would otherwise receive as of the date of the issuance of such securities in exchange for the Common Shares.

5

(iii) Exceptions. Notwithstanding the foregoing, a Common Holder will not be required to comply with clause (ii) directly above in connection with any proposed Sale of the Corporation (the “Proposed Sale”) unless:

(a) any representations and warranties to be made by such Common Holder in connection with the Proposed Sale are limited to representations and warranties related to authority, ownership and the ability to convey title to such Common Holder’s Common Shares, including but not limited to representations and warranties that (i) the Common Holder holds all right, title and interest in and to the Common Shares such Common Holder purports to hold, free and clear of all liens and encumbrances, (ii) the obligations of the Common Holder in connection with the transaction have been duly authorized, if applicable, (iii) the documents to be entered into by the Common Holder have been duly executed by the Common Holder and delivered to the acquirer and are enforceable against the Common Holder in accordance with their respective terms and (iv) neither the execution and delivery of documents to be entered into in connection with the transaction, nor the performance of the Common Holder’s obligations thereunder, will cause a breach or violation of the terms of any agreement, law or judgment, order or decree of any court or governmental agency;

(b) the Common Holder shall not be liable for the inaccuracy of any representation or warranty made by any other party in connection with the Proposed Sale, other than the Corporation (except to the extent that funds may be paid out of an escrow established to cover breach of representations, warranties and covenants of the Corporation as well as breach by any stockholder of any of identical representations, warranties and covenants provided by all stockholders);

(c) the liability for indemnification, if any, of such Common Holder in the Proposed Sale and for the inaccuracy of any representations and warranties made by the Corporation in connection with such Proposed Sale, is several and not joint with any other party (except to the extent that funds may be paid out of an escrow established to cover breach of representations, warranties and covenants of the Corporation as well as breach by any stockholder of any of identical representations, warranties and covenants provided by all stockholders), and is pro rata in proportion to the amount of consideration paid to such Common Holder in connection with such Proposed Sale;

(d) liability shall be limited to such Common Holder’s applicable share (determined based on the respective proceeds payable to all stockholders in connection with such Proposed Sale) of a negotiated aggregate indemnification amount that applies equally to all Common Holders but that in no event exceeds the amount of consideration otherwise payable to such Common Holder in connection with such Proposed Sale, except with respect to claims related to fraud by such Common Holder, the liability for which need not be limited as to such Common

6

Holder;

(e) upon the consummation of the Proposed Sale, (i) each holder of each class or series of the Corporation's stock will receive the same form of consideration for their shares of such class or series as is received by other holders in respect of their shares of such same class or series of stock, and (ii) each holder of Class A Voting Common Stock, Class B Non-Voting Common Stock and Class C Voting Common Stock will receive the same amount of consideration per share as is received by other holders in respect of their shares of such stock; and

(f) if such Common Holder is not an employee of the Corporation, such Common Holder is not required in connection with such Proposed Sale to agree to (i) any covenant not to compete with any party and/or (ii) any covenant not to solicit or hire customers, employees or suppliers of any party.

(iv) Irrevocable Proxy. To secure each Common Holder's obligations to vote the Common Shares in accordance with this Article FOURTH.C, each Common Holder hereby appoints the Chairman of the Board of Directors or the Chief Executive Officer of the Corporation, or either of them from time to time, or their designees, as such Common Holder's true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to vote all of such Common Holder's Common Shares as set forth in this Article FOURTH.C. and to execute all appropriate instruments consistent with this Article FOURTH.C on behalf of such Common Holder if, and only if, such Common Holder (a) fails to vote, or (b) attempts to vote (whether by proxy, in person or by written consent), in a manner which is inconsistent with the terms of this Article FOURTH.C, all of such Common Holder's Common Shares or execute such other instruments in accordance with the provisions of this Article FOURTH.C within five (5) days of the Corporation's or any other party's written request for such Common Holder's written consent or signature. The proxy and power granted by each Common Holder pursuant to this clause (iv) are coupled with an interest and are given to secure the performance of such party's duties under this Article FOURTH.C. Each such proxy and power will be irrevocable for the term hereof. The proxy and power, so long as any party hereto is an individual, will survive the death, incompetency and disability of such party or any other individual Common Holder of Common Shares and, so long as any party hereto is an entity, will survive the merger, consolidation, conversion or reorganization of such party or any other entity holding Common Shares.

(v) Remedies.

(a) Specific Enforcement. The Common Holders acknowledge and agree that each stockholder and the Corporation will be irreparably damaged in the event any of the provisions of this Article FOURTH.C are not performed by the Common Holders in accordance with their specific terms or are otherwise breached.

7

Accordingly, it is agreed that the Corporation shall be entitled to an injunction to prevent breaches of this Article FOURTH.C and to specific enforcement of this Article FOURTH.C and its terms and provisions in any action instituted in any court of the United States or any state having subject matter jurisdiction without the need to post any bond.

(b) Remedies Cumulative. All remedies, either under this Article by law or otherwise afforded to any party, shall be cumulative and not alternative.

(vi) Term. The provisions of this Article FOURTH.C shall continue in effect until and shall terminate upon the earliest to occur of (a) the consummation of a “Public Offering” (as defined below), or (b) the consummation of a transaction, in one transaction or a series of related transactions, that constitutes a Stock Sale, provided that the provisions of this Article FOURTH.C will continue after the closing of any Stock Sale to the extent necessary to enforce the provisions of this Article FOURTH.C with respect to such Stock Sale. “Public Offering” means the Corporation’s sale of its common stock in a underwritten public offering pursuant to a registration statement pursuant to the Securities Act, covering the offer and sale of common stock for the account of the Corporation or a direct listing public offering pursuant to a registration statement pursuant to the Securities Act covering the offer and sale of common stock for the account of the Corporation and/or security holders of the Corporation.

FIFTH: The name and mailing address of the incorporator is as follows:

Name: Timur Akilov
Mailing Address: 244 Madison Avenue, Suite 770, New York, NY 10016

SIXTH: The following provisions are inserted for the management of the business and for the conduct of the affairs of the Corporation and for the purpose of creating, defining, limiting and regulating the powers of the Corporation and its directors and stockholders.

(a) The number of directors of the Corporation shall be fixed and may be altered from time to time in the manner provided in the By-Laws, and any vacancy or vacancies in the Board of Directors and newly created directorships resulting from any increase in the authorized number of directors may be filled, and directors may be removed, as provided in the By-Laws.

(b) The election of directors need not be by ballot.

(c) All corporate powers and authority of the Corporation (except at the time otherwise provided by law, by this Amended and Restated Certificate of Incorporation or by the By-Laws) shall be under the direction of the Board of

8

Directors.

(d) The Board of Directors shall have the power without the assent or vote of the stockholders to adopt, amend, alter or repeal the By-Laws of the Corporation, except to the extent that the By-Laws otherwise provide.

**SEVENTH:** The Corporation shall, to the fullest extent permitted by Section 145 of the GCL, as the same may be amended and supplemented (i) indemnify all officers and directors of the Corporation from and against any and all expenses (including attorneys' fees), liabilities or other matters permitted by said section, and (ii) to the extent permitted by Section 145(e) of the GCL, as the same may be amended and supplemented, advance to each officer and director expenses (including attorneys' fees) incurred by such officers and directors in defending a civil or criminal action, suit or proceeding. The indemnification and advancement of expenses provided for herein shall not be deemed exclusive of any rights of indemnification or advancement of expenses to which any officer or director may be entitled under any By-Law, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in their official capacities and as to action in another capacity (provided such officer or director is acting in such other capacity at the request of the Corporation) while holding such offices, and shall continue as to persons who have ceased to be officers or directors of the Corporation and shall inure to the benefit of the heirs, executors and administrators of such persons.

A director of the Corporation shall not be liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director to the fullest permitted by the GCL. Any disinterested failure to satisfy GCL 365 shall not, for the purposes of GCL 102 (b) (7) or GCL 145, constitute an act or omission not in good faith, or a breach of the duty of loyalty.

IN WITNESS WHEREOF, this Amended and Restated Certificate of Incorporation has been executed by a duly authorized officer of this corporation on this 31$^{st}$ day of May, 2022.

CliqRex Inc.

James E. O'Loughlin, Chief Executive Officer

9

State of Delaware

Secretary of State

Division of Corporations

Delivered 11:26 AM 01/20/2022

FILED 11:26 AM 01/20/2022

SR 20220187100 - File Number 6563752

# STATE OF DELAWARE

# CERTIFICATE OF INCORPORATION

# A PUBLIC BENEFIT CORPORATION

FIRST: The name of the Corporation is CliqRex Inc.

SECOND: The Corporation's registered office in the State of Delaware is at 1013 Centre Road, Suite 403-B, in the City of Wilmington, County of New Castle, 19805. The name of its registered agent at that address is VCorp Service LLC.

THIRD: The specific public benefit purpose of the Corporation is to provide support to vulnerable communities by way of donations and engagement with community based organizations. In addition, the Corporation may engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware as the same exists or may hereafter be amended ("GCL").

FOURTH: A. Authorized Capital Stock. The total number of shares of stock which the Corporation shall have the authority to issue is 11,000,000 shares of common stock with a par value of $0.00001 per share (the "Common Stock"), which may be issued in two series: (i) 10,000,000 shares of Class A voting common stock ("Voting Common Stock") and (ii) 1,000,000 shares of Class B non-voting common stock ("Non-Voting Common Stock"). The number of authorized shares of Common Stock may be increased or decreased (but not below the number of shares of Common Stock then outstanding) by such affirmative vote of the votes entitled to be cast thereon as may be required at that time by the GCL.

B. Voting Common Stock and Non-Voting Common Stock.

(i) Ranking. The preferences, limitations and rights of the Voting Common Stock and Non-Voting Common Stock, and the qualifications and restrictions thereof, shall be in all respects identical, except as otherwise required by law or expressly provided in this Certificate of Incorporation.

(ii) Voting. Except as otherwise required by law or in this Certificate of Incorporation (as it may be hereafter be amended), with respect to all matters upon which stockholders are entitled to vote or to which stockholders are entitled to give consent, the holders of any outstanding shares of the Voting Common Stock shall vote together as a single class, and every holder of the Voting Common Stock shall be entitled to cast thereon one (1) vote in person or by proxy for each share of the Voting Common Stock standing in such holder's name. Except as otherwise required by law or in this Certificate of Incorporation (as it may be hereafter be amended), the holders of the outstanding shares of Non-Voting Common Stock shall not be entitled to vote on any matter, including any amendment to this Certificate of Incorporation.

(iii) Amendments Affecting Stock. So long as any shares of Non-Voting Common Stock are outstanding, the Corporation shall not, without such affirmative vote of the votes entitled to be cast on the amendment by the holders of outstanding shares of Non-Voting Common Stock voting as a single class as may be required at that time by the GCL (i) amend, alter or repeal any provision of this Section B of this Article FOURTH so as to affect adversely the relative rights, preferences, qualifications, limitations or restrictions of the Non-Voting Common Stock as compared to those of the Voting Common Stock, or (ii) take any other action upon which class voting of the Non-Voting Common Stock is required by law.

(iv) Dividends: Changes in Stock. No dividend or distribution may be declared or paid on any share of Voting Common Stock unless a dividend or distribution, payable in the same consideration and manner, is simultaneously declared or paid, as the case may be, on each share of Non-Voting Common Stock, nor shall any dividend or distribution be declared or paid on any share of Non-Voting Common Stock unless a dividend or distribution, payable in the same consideration and manner, is simultaneously declared or paid, as the case may be, on each share of Voting Common Stock, in each case without preference or priority of any kind; provided, however, that if dividends are declared that are payable in shares of Voting Common Stock or in Non-Voting Common Stock or in rights, options, warrants or other securities convertible into or exchangeable for shares of Voting Common Stock or Non-Voting Common Stock, dividends shall be declared that are payable at the same rate on both series of Common Stock and dividends payable in shares of Voting Common Stock or in rights, options, warrants or other securities convertible into or exchangeable for shares of Voting Common Stock shall be payable to holders of Voting Common Stock and dividends payable in shares of Non-Voting Common Stock or in rights, options, warrants or other securities convertible into or exchangeable for shares of Non-Voting Common Stock shall be payable to holders of Non-Voting Common Stock. If the Corporation in any manner subdivides or combines the outstanding shares of Non-Voting Common Stock, the outstanding shares of Voting Common Stock shall be proportionately subdivided or combined, as the case may be. Similarly, if the Corporation in any manner subdivides or combines the outstanding shares of Voting Common Stock, the outstanding shares of Non-Voting Common Stock shall be proportionately subdivided or combined, as the case may be.

(v) Liquidation. Shares of Non-Voting Common Stock shall rank pari passu with shares of Voting Common Stock as to distribution of assets in the event of any liquidation, dissolution or winding up of the affairs of the Corporation.

(vi) Merger or Consolidation. In the event of a merger or consolidation of the Corporation with or into another entity (whether or not the Corporation is the surviving entity), the holders of each share of Voting Common Stock and Non-Voting Common Stock shall be entitled to receive the same per share consideration as the per share consideration, if any, received by the holders of each share of such other series of Common Stock.

FIFTH: The name and mailing address of the incorporator is as follows:

Name: Timur Akilov

Mailing Address: 162 Falmouth St. Brooklyn, NY 11235

SIXTH: The following provisions are inserted for the management of the business and for the conduct of the affairs of the Corporation and for the purpose of creating, defining, limiting and regulating the powers of the Corporation and its directors and stockholders.

(a) The number of directors of the Corporation shall be fixed and may be altered from time to time in the manner provided in the By-Laws, and any vacancy or vacancies in the Board of Directors and newly created directorships resulting from any increase in the authorized number of directors may be filled, and directors may be removed, as provided in the By-Laws.
(b) The election of directors need not be by ballot.
(c) All corporate powers and authority of the Corporation (except at the time otherwise provided by law, by this Certificate of Incorporation or by the By-Laws) shall be under the direction of the Board of Directors.
(d) The Board of Directors shall have the power without the assent or vote of the stockholders to adopt, amend, alter or repeal the By-Laws of the Corporation, except to the extent that the By-Laws otherwise provide.

SEVENTH: The Corporation shall, to the fullest extent permitted by Section 145 of the GCL, as the same may be amended and supplemented, (i) indemnify all officers and directors of the Corporation from and against any and all expenses (including attorneys' fees), liabilities or other matters permitted by said section, and (ii) to the extent permitted by Section 145(e) of the GCL, as the same may be amended and supplemented, advance to each officer and director expenses (including attorneys' fees) incurred by such officers and directors in defending a civil or criminal action, suit or proceeding. The indemnification and advancement of expenses provided for herein shall not be deemed exclusive of any rights of indemnification or advancement of expenses to which any officer or director may be entitled under any By-Law, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in their official capacities and as to action in another capacity (provided such officer or director is acting in such other capacity at the request of the Corporation) while holding such offices, and shall continue as to persons who have ceased to be officers or directors of the Corporation and shall inure to the benefit of the heirs, executors and administrators of such persons.

A director of the Corporation shall not be liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director to the fullest

permitted by the GCL. Any disinterested failure to satisfy GCL 365 shall not, for the purposes of GCL 102 (b) (7) or GCL 145, constitute an act or omission not in good faith, or a breach of the duty of loyalty.

IN WITNESS WHEREOF, the undersigned, being the incorporator hereinabove named, for the purpose of forming a corporation pursuant to the General Corporation Law of the State of Delaware does make and file this Certificate hereby declaring and certifying that the facts herein stated are true, and accordingly has hereunto set his name this 20th day of January, 2022.

![img-0.jpeg](img-0.jpeg)

Timur Akilov

**Attachment 4:** `corporatebylaws.pdf`

# CLIQREX INC.

# AMENDED AND RESTATED BY-LAWS

As Adopted on May 31, 2022

# **ARTICLE I**

# **STOCKHOLDERS**

Section 1.01 *Annual Meetings*. The annual meeting of the stockholders of the Corporation for the election of Directors and for the transaction of such other business as properly may come before such meeting shall be held each year on the first Wednesday of March, or on such other date and at such place, within or without the State of Delaware, as the Board of Directors may fix.

Section 1.02 *Special Meetings*. Special meetings of the stockholders may be called at any time by the Chairman of the Board (if one has been elected), the President, the Chief Executive Officer or by the Board of Directors. A special meeting shall be called by the Chairman of the Board (if one has been elected), the President, the Chief Executive Officer or by the Secretary, immediately upon receipt of a written request therefor by stockholders holding a majority of the outstanding shares of Class A Voting Common Stock at the time entitled to vote at any meeting of the holders of the Class A Voting Common Stock. While holders of Class C Voting Common Stock of the Corporation have no right to call meetings of the stockholders, such holders may vote their shares of Class C Voting Common Stock at properly called stockholder meetings (however holders of Class C Common Stock will have no right to vote with respect to the election of directors of the Corporation, their removal as members of the Board of Directors of the

1

Corporation or the size of the Board of Directors of the Corporation). If such officers shall fail to call such meeting within twenty days after receipt of such request, any holder of Class A Voting Common Stock executing such request may call such meeting. Such special meetings of the holders of the Class A Voting Common Stock shall be held at such places, within or without the State of Delaware, as shall be specified in the respective notices or waivers of notice thereof.

Section 1.03 Notice of Meetings; Waiver. Written notice of the place, date and hour of all meetings of the holders of the Class A Voting Common Stock or Class C Voting Common Stock and, in the case of a special meeting, the purpose or purposes for which the meeting is called shall be given, not less than ten days nor more than sixty days before the date on which the meeting is to be held, to each stockholder entitled to vote at such meeting, except as otherwise provided herein or required by law. If mailed, notice is given to a stockholder when deposited in the United States mail, postage prepaid, directed to the stockholder at his, her or its address as it appears on the record of stockholders of the Corporation, or, if he, she or it shall have filed with the Secretary of the Corporation a written request that notices to him, her or it be mailed to some other address then directed to him, her or it at such other address. Such further notice shall be given as may be required by law. Except as provided in Section 1.07 of these By-Laws, notice of any adjourned meeting of the stockholders of the Corporation need not be given. No notice of any meeting of stockholders need be given to any stockholder who submits a signed waiver of notice, whether before or after the meeting. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders need be specified in a written waiver of notice. The attendance of any stockholder at a meeting of stockholders shall constitute a waiver of notice of

2

such meeting, except when the stockholder attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business on the ground that the meeting is not lawfully called or convened.

Section 1.04 *Quorum*. Except as otherwise required by law, by the Articles of Incorporation or any written agreement entered into by the stockholders of the Corporation, the presence in person or by proxy of the holders of record of a majority of the shares of stock entitled to vote at a meeting of stockholders shall constitute a quorum for the transaction of business at such meeting.

Section 1.05 *Voting*. If, pursuant to Section 4.05 of these By-Laws, a record date has been fixed, every holder of record of shares of (i) Class A Voting Common Stock shall be entitled to two (2) votes for each share of stock outstanding in his, her or its name on the books of the Corporation at the close of business on such record date, and (ii) Class C Voting Common Stock shall be entitled to one (1) vote for each share of stock outstanding in his, her or its name on the books of the Corporation at the close of business on such record date. If no record date has been fixed, then every holder of record of shares of stock entitled to vote at a meeting of stockholders shall be entitled to such number of votes as is set forth above for each share of stock outstanding in his, her or its name on the books of the Corporation at the close of business on the day next preceding the day on which notice of the meeting is given, or if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. Except as otherwise required by law, by the Articles of Incorporation, by these By-Laws or by a written agreement entered into by the Corporation’s stockholders, the vote of a majority of the shares of stock entitled

3

to vote at a meeting represented in person or by proxy at any meeting at which a quorum is present shall be sufficient for the transaction of any business of such meeting.

Section 1.06 Voting by Ballot. No vote of the stockholders need be taken by written ballot, unless otherwise required by law or requested by any stockholder. Any vote which need not be taken by ballot may be conducted in any manner approved by the stockholders at the meeting.

Section 1.07 Adjournment. If a quorum is not present at any meeting of the stockholders, the stockholders present in person or by proxy entitled to vote at the meeting shall have the power to adjourn any such meeting from time to time until a quorum is present. Notice of any adjourned meeting of the stockholders of the Corporation need not be given if the place, date and hour thereof are announced at the meeting at which the adjournment is taken, provided, however, that if the adjournment is for more than thirty days, or if after the adjournment a new record date for the adjourned meeting is fixed pursuant to Section 4.05 of these By-Laws, a notice of the adjourned meeting, conforming to the requirements of Section 1.03 hereof, shall be given to each stockholder of record entitled to vote at such meeting. At any adjourned meeting at which a quorum is present, any business may be transacted that might have been transacted on the original date of the meeting.

Section 1.08 Proxies. Any stockholder entitled to vote at any meeting of the stockholders or to express consent to or dissent from corporate action without a meeting may, by a written instrument signed by such stockholder or his, her or its attorney-in-fact, authorize another person or persons to vote at any such meeting and express such consent or dissent for him, her or it

4

by proxy. No such proxy shall be voted or acted upon after the expiration of three years from the date of such proxy, unless such proxy provides for a longer period. Every proxy shall be revocable at the pleasure of the stockholder executing it, except in those cases where applicable law provides that a proxy shall be irrevocable.

Section 1.09 Organization; Procedures. At every meeting of stockholders the presiding officer shall be the Chairman of the Board (if one has been elected) or, in the event of his or her absence or disability, in rotating years the Chief Executive Officer or, in his or her absence, the President if there is one or, in the event of their absence or disability, a presiding officer chosen by a majority of the stockholders entitled to vote at the meeting present in person or by proxy. The Secretary, or in the event of his or her absence or disability, an appointee of the presiding officer, shall act as Secretary of the meeting. The order of business and all other matters of procedure at every meeting of stockholders may be determined by such presiding officer.

Section 1.10 Consent of Stockholders in Lieu of Meeting. To the fullest extent permitted by law, whenever the vote of stockholders at a meeting thereof is required or permitted to be taken for or in connection with any corporate action, such action may be taken without a meeting, without prior notice and without a vote of stockholders, if the holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted shall consent in writing to such corporate action being taken. Prompt notice of the taking of corporate action without a meeting by less than unanimous written consent shall be given to those stockholders who have not so consented in writing.

5

# ARTICLE II

## BOARD OF DIRECTORS

Section 2.01 General Powers. Except as may otherwise be provided by law, by the Articles of Incorporation or by these By-Laws, the property, affairs and business of the Corporation shall be managed under the direction of the Board of Directors.

Section 2.02 Number and Term of Office. The Board of Directors shall be composed of not less than one (1) and not more than five (5) directors, and shall be initially composed of two (2) members. The number of Directors may be increased by resolution adopted by a majority vote of the Board. Each Director (whenever elected) may hold office until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal.

Section 2.03 Election of Directors. Except as otherwise provided in Sections 2.13 of these By-Laws, the Directors shall be elected at each annual meeting of the holders of the Class A Voting Common Stock. If the annual meeting for the election of Directors is not held on the date designated therefor, the Directors shall cause the meeting to be held as soon thereafter as convenient. At each meeting of the holders of the Class A Voting Common Stock for the election of Directors, provided a quorum is present, the Directors shall be elected by a plurality of the votes validly cast in such election.

Section 2.04 Qualifications of Directors. Each Director shall be at least 18 years of age. Directors need not be stockholders.

Section 2.05 Annual and Regular Meetings. The annual meeting of the Board of

6

Directors for the purpose of electing officers and for the transaction of such other business as may come before the meeting shall be held as soon as possible following adjournment of the annual meeting of the holders of the Class A Voting Common Stock at the place of such annual meeting of such stockholders. Notice of such annual meeting of the Board of Directors need not be given. The Board of Directors from time to time may by resolution provide for the holding of regular meetings and fix the place (which may be within or without the State of Delaware) and the date and hour of such meetings. Notice of regular meetings need not be given, provided, however, that if the Board of Directors shall fix or change the time or place of any regular meeting, notice of such action shall be mailed promptly, or sent by email or facsimile, to each Director who shall not have been present at the meeting at which such action was taken, addressed to him or her at his or her usual place of business, or shall be delivered to him or her personally. Notice of such action need not be given to any Director who attends the first regular meeting after such action is taken without protesting the lack of notice to him or her, prior to or at the commencement of such meeting, or to any Director who submits a signed waiver of notice, whether before or after such meeting.

Section 2.06 Special Meetings; Notice. Special meetings of the Board of Directors shall be held whenever called by the Chairman of the Board (if one has been elected), or by the President or Chief Executive Officer at such place (within or without the State of Delaware), date and hour as may be specified in the respective notices or waivers of notice of such meetings. Special meetings of the Board of Directors may be called on 24 hours notice, if notice is given to each Director personally or by telephone, email or facsimile, or on five days' notice, if notice is mailed to each Director, addressed to him or her at his or her usual place of business. Notice of any

7

special meeting need not be given to any Director who attends such meeting without protesting the lack of notice to him or her, prior to or at the commencement of such meeting, or to any Director who submits a signed waiver of notice, whether before or after such meeting.

Section 2.07 *Quorum; Voting*. At all meetings of the Board of Directors, the presence of a majority of the total authorized number of Directors shall constitute a quorum for the transaction of business. Except as otherwise required by law, the vote of a majority of the Directors present at any meeting at which a quorum is present shall be the act of the Board of Directors.

Section 2.08 *Adjournment*. A majority of the Directors present, whether or not a quorum is present, may adjourn any meeting of the Board of Directors to another time or place. No notice need be given of any adjourned meeting unless the time and place of the adjourned meeting are not announced at the time of adjournment, in which case notice conforming to the requirements of Section 2.06 shall be given to each Director.

Section 2.09 *Action Without a Meeting*. Any action required or permitted to be taken at any meeting of the Board of Directors may be taken without a meeting if all members of the Board of Directors consent thereto in writing, and such writing or writings are filed with the minutes of proceedings of the Board of Directors.

Section 2.10 *Regulations; Manner of Acting*. To the extent consistent with applicable law, the Articles of Incorporation and these By-Laws, the Board of Directors may adopt such rules and regulations for the conduct of meetings of the Board of Directors and for the management of the property, affairs and business of the Corporation as the Board of Directors may deem appropriate. The Directors shall act only as a Board, and the individual Director shall have no

8

power as such.

Section 2.11 Action by Telephonic Communications. Members of the Board of Directors may participate in a meeting of the Board of Directors by means of conference telephone, teleconference (including via the internet) or any similar communications equipment by means of which all persons participating in the meeting can hear each other, and participation in a meeting pursuant to this provision shall constitute presence in person at such meeting.

Section 2.12 Resignations. Any Director may resign at any time by delivering a written notice of resignation, signed by such Director, to the Board of Directors, the Chairman of the Board (if one has been elected), the President, the Chief Executive Officer or the Secretary. Unless otherwise specified therein, such resignation shall take effect upon delivery.

Section 2.13 Vacancies and Newly Created Directorships. If any vacancies shall occur in the Board of Directors by reason of death, resignation, removal or otherwise, or if the authorized number of Directors shall be increased, the Directors then in office shall continue to act, and such vacancies and newly created directorships may be filled by a majority of the Directors then in office, although less than a quorum, or as otherwise provided in any Stockholders’ Agreement of the Corporation. A Director elected to fill a vacancy or a newly created directorship shall hold office until his or her successor has been elected and qualified or until his or her earlier death, resignation or removal. Any such vacancy or newly created directorship may also be filled at any time by vote of the holders of the Class A Voting Common Stock, subject to the terms of any Stockholders’ Agreement of the Corporation.

Section 2.15 Compensation. The amount, if any, which each Director shall be

9

entitled to receive as compensation for his or her services as such shall be fixed from time to time by resolution of the Directors.

Section 2.16 Reliance on Accounts and Reports, etc. A Director shall, in the performance of his or her duties, be fully protected in relying in good faith upon the books of account or reports made to the Corporation by any of its officers, or by an independent certified public accountant, or by an appraiser selected with reasonable care by the Board of Directors, or in relying in good faith upon other records of the Corporation.

### ARTICLE III

#### OFFICERS

Section 3.01 Number. The officers of the Corporation shall be chosen by the Board of Directors and shall be a Chief Executive Officer, a President, if the Board of Directors so elects, a Secretary and a Treasurer. The Board of Directors also may elect a Chairman of the Board, one or more Vice Presidents, in such numbers as the Board of Directors may determine, a Chief Financial Officer and a Chief Operating Office. Any number of officers may be held by the same person.

Section 3.02 Election. Unless otherwise determined by the Board of Directors, the officers of the Corporation shall be elected by the Board of Directors at the annual meeting of the Board of Directors, and shall be elected to hold office until the next succeeding annual meeting of the Board of Directors. In the event of the failure to elect officers at such annual meeting, officers may be elected at any regular or special meeting of the Board of Directors. Each officer shall hold office until his or her successor has been elected and qualified, or until his or her earlier death, resignation or removal.

10

Section 3.03 Compensation. The compensation of all officers and agents of the Corporation shall be fixed from time to time by the Board of Directors.

Section 3.04 Removal and Resignation; Vacancies. Subject to the terms of any Stockholders' Agreement of the Corporation, any officers may be removed with or without cause at any time by the Board of Directors. Any officer may resign at any time by delivering a written notice of resignation, signed by such officer, to the Board of Directors, the Chairman of the Board (if one has been elected), the President (if one has been elected), the Chief Executive Officer or the Secretary. Unless otherwise specified therein, such resignation shall take effect upon delivery. Any vacancy occurring in any office of the Corporation by death, resignation, removal or otherwise, may be filled only by the Board of Directors.

Section 3.05 Authority and Duties of Officers. The officers of the Corporation shall have such authority and shall exercise such powers and perform such duties as may be specified in these By-Laws or in a resolution of the Board of Directors which is not inconsistent with the By-Laws, except that in any event each officer shall exercise such powers and perform such duties as may be required by law.

Section 3.06 The Chairman of the Board. The Chairman of the Board (if one has been elected) shall preside at all meetings of the stockholders and Directors at which he is present, and shall exercise such other powers and perform such other duties as may from time to time be assigned to him or her by these By-Laws or by the Board of Directors.

Section 3.07 The Chief Executive Officer. The Chief Executive Officer (and, in his absence, if one has been elected, the President) shall each have the following powers and duties:

11

(a) He or she shall, subject to the directions of the Board of Directors, have general charge of the business and affairs of the Corporation and general supervision over its other officers, employees and agents.

(b) Subject to the directions of the Board of Directors, he or she shall exercise all powers and perform all duties incident to the office of a chief executive officer of a corporation, and shall exercise such other powers and perform such other duties as from time to time may be assigned to him or her by these By-Laws or by the Board of Directors.

(c) In the event of the absence or disability of the Chairman of the Board, the Chief Executive Officer shall preside at all meetings of stockholders and Directors.

Section 3.08 The Vice Presidents. Each Vice President shall exercise such powers and perform such duties as from time to time may be assigned to him or her by these By-Laws or by the Board of Directors or by the President (if one has been elected) or Chief Executive Officer. In the absence of the Chief Executive Officer or the President (if one has been elected), and Executive Vice President may exercise the powers of the Chief Executive Officer.

Section 3.09 The Secretary. The Secretary shall have the following powers and duties:

(a) He or she shall keep or cause to be kept a record of all the proceedings of the meetings of the stockholders and of the Board of Directors in books provided for that purpose.

(b) He or she shall cause all notices to be duly given in accordance with the

12

provisions of these By-Laws and as required by law.

(c) He or she shall be the custodian of the records and of the seal of the Corporation and cause such seal (or a facsimile thereof) to be affixed to all certificates representing shares of the Corporation prior to the issuance thereof and to all instruments the execution of which on behalf of the Corporation under its seal shall have been duly authorized in accordance with these By-Laws, and when so affixed he or she may attest the same.

(d) He or she shall properly maintain and file all books, reports, statements, certificates and all other documents and records required by law, the Articles of Incorporation or these By-Laws.

(e) He or she shall have charge of the stock books and ledgers of the Corporation and shall cause the stock and transfer books to be kept in such manner as to show at any time the number of shares of stock of the Corporation of each class issued and outstanding, the names and the addresses of the holders of record of such shares, the number of shares held by each holder and the date as of which each became such holder of record.

(f) He or she shall sign (unless the Treasurer, an Assistant Treasurer or Assistant Secretary shall have signed) certificates representing shares of the Corporation the issuance of which shall have been authorized by the Board of Directors.

(g) He or she shall perform, in general, all duties incident to the office of Secretary and such other duties as may be given to him or her by these By-Laws or as may be

13

assigned to him or her from time to time by the Board of Directors or the Chief Executive Officer.

Section 3.10 The Treasurer. The Treasurer shall have the following powers and

duties:

(a) He or she shall have charge and supervision over and be responsible for the monies, securities, receipts and disbursements of the Corporation, and shall keep or cause to be kept full and accurate records of all receipts of the Corporation.
(b) He or she shall cause the monies and other valuable effects of the Corporation to be deposited in the name and to the credit of the Corporation in such banks or trust companies or with such bankers or other depositories as shall be selected in accordance with Section 7.05 of these By-Laws.
(c) He or she shall cause the monies of the Corporation to be disbursed by checks or drafts (signed as provided in Section 7.06 of these By-Laws) upon the authorized depositories of the Corporation and cause to be taken and preserved proper vouchers for all monies disbursed.
(d) He or she shall render to the Board of Directors, the Chairman of the Board or the Chief Executive Officer, whenever requested, a statement of the financial condition of the Corporation and of all his or her transactions as Treasurer, and render a full financial report at the annual meeting of the stockholders, if called upon to do so.
(e) He or she shall be empowered from time to time to require from all officers or

14

agents of the Corporation reports or statements giving such information as he or she may desire with respect to any and all financial transactions of the Corporation.

(f) He or she may sign (unless an Assistant Treasurer or the Secretary or an Assistant Secretary shall have signed) certificates representing stock of the Corporation the issuance of which shall have been authorized by the Board of Directors.

(g) He or she shall perform, in general, all duties incident to the office of Treasurer and such other duties as may be given to him or her by these By-Laws or as may be assigned to him or her from time to time by the Board of Directors or the Chief Executive Officer.

Section 3.11 Additional Officers. The Board of Directors may appoint such other officers and agents as it may deem appropriate, and such other officers and agents shall hold their offices for such terms and shall exercise such powers and perform such duties as may be determined from time to time by the Board of Directors. The offices of Chairman of the Board and President or Chairman of the Board and Chief Executive Officer may be held by the same person.

## ARTICLE IV

### CAPITAL STOCK

Section 4.01 Certificates of Stock. Every holder of stock in the Corporation shall be entitled to have a certificate signed by, or in the name of the Corporation by the Chairman of the Board or the Chief Executive Officer (or a President if one has been elected) or by a Vice President and by the Treasurer or the Secretary certifying the number of shares owned by him, her or it in the

15

Corporation. Such certificate shall be in such form as the Board of Directors determine, to the extent consistent with applicable law, the Articles of Incorporation and these By-Laws.

Section 4.02 Signatures; Facsimile. Any of or all the signatures on the certificate may be a facsimile. In case any officer, transfer agent or registrar who has signed, or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the Corporation with the same effect as if he were such officer, transfer agent or registrar at the date of issue.

Section 4.03 Lost, Stolen or Destroyed Certificates. The Board of Directors may direct that a new certificate be issued in place of any certificate theretofore issued by the Corporation alleged to have been lost, stolen or destroyed, upon delivery to the Board of Directors of an affidavit of the owner or owners of such certificate, setting forth such allegation. The Board of Directors may require the owner of such lost, stolen or destroyed certificate, or his or her legal representative, to give the Corporation a bond sufficient to indemnify it against any claim that may be made against it on account of the alleged loss, theft or destruction of any such certificate or the issuance of any such new certificate.

Section 4.04 Transfer of Stock. Upon surrender to the Corporation or the transfer agent of the Corporation of a certificate for shares, duly endorsed or accompanied by appropriate evidence of succession, assignment or authority to transfer, the Corporation shall issue a new certificate to the person entitled thereto, cancel the old certificate and record the transaction upon its books. Subject to the provisions of the Articles of Incorporation and these By-Laws, the Board of Directors may prescribe such additional rules and regulations as it may deem appropriate relating to

16

the issue, transfer and registration of shares of the Corporation.

Section 4.05 *Record Date*. In order to determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, or to express consent to corporate action in writing without a meeting, or entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board of Directors may fix, in advance, a record date, which shall not be more than sixty nor less than ten days before the date of such meeting, nor more than sixty days prior to any other action. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting, provided, however, that the Board of Directors may fix a new record date for the adjourned meeting.

Section 4.06 *Registered Stockholders*. Prior to due surrender of a certificate for registration of transfer, the Corporation may treat the registered owner as the person exclusively entitled to receive dividends and other distributions, to vote, to receive notice and otherwise to exercise all the rights and powers of the owner of the shares represented by such certificate, and the Corporation shall not be bound to recognize any equitable or legal claim to or interest in such shares on the part of any other person, whether or not the Corporation shall have notice of such claim or interests. Whenever any transfer of shares shall be made for collateral security, and not absolutely, it shall be so expressed in the entry of the transfer if, when the certificates are presented to the Corporation for transfer, both the transferor and transferee request the Corporation to do so.

Section 4.07 *Transfer Agent and Registrar*. The Board of Directors may appoint

17

one or more transfer agents and one or more registrars, and may require all certificates representing shares to bear the signature of any such transfer agents or registrars.

## ARTICLE V

### INDEMNIFICATION

Section 5.01 *Indemnification*. The Corporation shall, to the fullest extent permitted by applicable law from time to time in effect, indemnify any and all persons who may serve or who have served at any time as Directors or officers of the Corporation, or who at the request of the Corporation may serve or at any time have served as Directors or officers of another corporation (including subsidiaries of the Corporation) or of any partnership, joint venture, trust or other enterprise, from and against any and all of the expenses, liabilities or other matters referred to in or covered by said law. Such indemnification shall continue as to a person who has ceased to be a Director or officer and shall inure to the benefit of the heirs, executors and administrators of such a person. The Corporation may also indemnify any and all other persons whom it shall have power to indemnify under any applicable law from time to time in effect to the extent authorized by the Board of Directors and permitted by such law. The indemnification provided by this Article shall not be deemed exclusive of any other rights to which any person may be entitled under any provision of the Articles of Incorporation, other By-Laws, agreement, vote of stockholders or disinterested Directors, or otherwise, both as to action in his or her official capacity and as to action in another capacity while holding such office.

Section 5.02 *Definition*. For purposes of this Article, the term “Corporation” shall include constituent corporations referred to in subsection (h) of Section 145 of the General

18

Corporation Law of the State of Delaware (or any similar provision of applicable law at the time in effect).

## ARTICLE VI

### OFFICES

Section 6.01 *Registered Office*. The registered office of the Corporation in the State of Delaware shall be located at 1013 Centre Road, Suite 403-B, in the City of Wilmington, County of New Castle, 19805. The name of its registered agent at that address is VCorp Service LLC.

Section 6.02 *Other Offices*. The Corporation may maintain offices or places of business at such other locations within or without; the State of Delaware as the Board of Directors may from time to time determine or as the business of the Corporation may require.

## ARTICLE VII

### GENERAL PROVISIONS

Section 7.01 *Dividends*. Subject to any applicable provisions of law and the Articles of Incorporation, dividends upon the shares of the Corporation may be declared by the Board of Directors at any regular or special meeting of the Board of Directors and any such dividend may be paid in cash, property, or shares of the Corporation.

Section 7.02 *Reserve*. There may be set apart from time to time out of any funds of the Corporation available for dividends such reserve or reserves as the Board of Directors may determine and the Board of Directors may similarly modify or abolish any such reserve or reserves.

Section 7.03 *Execution of Instruments*. The Chief Executive Officer (or the President, if one has been elected), subject to the approval of the Board of Directors, may enter into

19

any contract or execute and deliver any instrument in the name and on behalf of the Corporation. The Board of Directors may authorize any other officer or agent to enter into any contract or execute and deliver any instrument in the name and on behalf of the Corporation. Any such authorization may be general or limited to specific contracts or instruments.

Section 7.04 *Corporate Indebtedness*. No loan shall be contracted on behalf of the Corporation, and no evidence of indebtedness shall be issued in its name, unless authorized by the Board of Directors. Such authorization may be general or confined to specific instances. Loans so authorized may be effected at any time for the Corporation from any bank, trust company or other institution, or from any firm, corporation or individual. All bonds, debentures, notes and other obligations or evidences of indebtedness of the Corporation issued for such loans shall be made, executed and delivered as the Board of Directors shall authorize. When so authorized by the Board of Directors, any part of or all the properties, including contract rights, assets, business or good will of the Corporation, whether then owned or thereafter acquired, may be mortgaged, pledged, hypothecated or conveyed or assigned in trust as security for the payment of such bonds, debentures, notes and other obligations or evidences of indebtedness of the Corporation, and of the interest thereon, by instruments executed and delivered in the name of the Corporation.

Section 7.05 *Deposits*. Any funds of the Corporation may be deposited from time to time in such banks, trust companies or other depositories as may be determined by the Board of Directors, or by such officers or agents as may be authorized by the Board of Directors to make such determination.

Section 7.06 *Checks*. All notes, drafts, bills of exchange, acceptances, checks,

20

endorsements and other evidences of indebtedness of the Corporation, and its orders for the payment of money, shall be signed by such officer or officers or such agent or agents of the Corporation, and in such manner, as the Board of Directors from time to time may determine.

Section 7.07 Sale, Transfer, etc. of Securities. The Chief Executive Officer (or the President, if one has been elected), together with the Secretary or Treasurer to the extent authorized by the Board of Directors, may sell, transfer, endorse, and assign any shares of stock, bonds or other securities owned by or held in the name of the Corporation, and may make, execute and deliver in the name of the Corporation, under its corporate seal, any instruments that may be appropriate to effect any such sale, transfer, endorsement or assignment.

Section 7.08 Voting as Stockholder. Unless otherwise determined by resolution of the Board of Directors, the Chief Executive Officer (the President, if one has been elected) shall each have full power and authority on behalf of the Corporation to attend any meeting of stockholders of any corporation in which the Corporation may hold stock, and to act, vote (or execute proxies to vote) and exercise in person or by proxy all other rights, powers and privileges incident to the ownership of such stock. Such officer acting on behalf of the Corporation shall have full power and authority to execute any instrument expressing consent to or dissent from any action of any such corporation without a meeting. The Board of Directors may by resolution from time to time confer such power and authority upon any other person or persons.

Section 7.09 Fiscal Year. Unless otherwise determined by the Board of Directors, the fiscal year of the Corporation shall commence on the first day of January and shall end on the thirty-first day of December of the following year.

21

Section 7.10 Seal. The seal of the Corporation shall be circular in form and shall contain the name of the Corporation, the year of its incorporation and the words “Corporate Seal” and “Delaware”. The form of such seal shall be subject to alteration by the Board of Directors. The seal may be used by causing it or a facsimile thereof to be impressed, affixed or reproduced, or may be used in any other lawful manner.

Section 7.11 Books and Records; Inspection. Except to the extent otherwise required by law, the books and records of the Corporation shall be kept at such place or places within or without the State of Delaware as may be determined from time to time by the Board of Directors.

Section 7.12 Stockholders’ Agreement. Should the Corporation enter into a stockholders’ agreement with its stockholders, in the event of any conflict between these By-Laws and such agreement, the terms of such agreement will prevail.

## ARTICLE VIII

### AMENDMENT OF BY-LAWS

Section 8.01 Amendment. These By-Laws may be amended, altered or repealed at any regular or special meeting of the holders of the Class A Voting Common Stock and the Class C Voting Common Stock (however the holders of Class C Voting Common Stock will have no right to vote with respect to any amendment which relates to the election or of the Board of Directors, the removal of a member of the Board of Directors or the size of the Board of Directors of the Corporation) if, in the case of such special meeting only, notice of such amendment, alteration or repeal is contained in the notice or waiver of notice of such meeting.

22

**Attachment 5:** `otherfinancial.pdf`

# Record Ownership and Voting Agreement

This Record Ownership and Voting Agreement (this “Agreement”) is entered into as of the date of electronic consent by the parties using the website www.netcapital.com (the “Portal”), by and among NetCapital Funding Portal Inc., a Delaware corporation (“NetCapital”), MG Teixeira Inc, a Connecticut corporation (the “Record Owner”), and the undersigned investor (“Investor”).

The Record Owner has agreed to open and maintain the Account (as defined below) for Investor and to provide other services to Investor in connection with the Account. This Agreement sets out, among other things, the terms under which the Record Owner will provide those services to Investor and the arrangements that will apply in connection with those services.

In consideration of the mutual promises herein made and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows:

## 1. Interpretation

### 1.1 Definitions

In this Agreement:

- • “Account” means the account opened by the Record Owner and consisting of the beneficial interests in any Shares that were offered for sale by the Issuer on the Portal and purchased by Investor.
- • “Account Balance” means, in relation to the Account, the number of Shares of each Issuer beneficially owned by Investor, including all of Investor’s rights to and interest in the balance from time to time on that Account.
- • “Business Day” means a weekday that is not a federal holiday.
- • “Escrow Agent” means Boston Private Bank and Trust Company.
- • “Fees” means the fees and charges referred to in clause 5.1 of this Agreement.
- • “Issuer” means each issuer of the Shares.
- • “Shares” means the beneficial interests in the uncertificated shares of common stock or preferred stock or the units of convertible debt, limited liability company membership interests or limited partnership interests that were beneficially purchased by Investor on the Portal.
- • “Termination Date” means the date on which this Agreement is terminated by the Record Owner or by Investor as permitted hereunder.
- • “Transfer Agent” means Equity Stock Transfer LLC, or a successor transfer agent.
- • “Withdrawal Date” means the date referred to in clause 2.2 of this Agreement.

### 1.2. Headings

The headings in this Agreement do not affect its interpretation.

### 1.3. Singular and plural

References to the singular include the plural and vice versa.

## 2. Account

### 2.1. Opening Account

The Record Owner shall open and maintain the Account for the beneficial interests in the Shares beneficially held by Investor.

### 2.2. Deposits and withdrawals

The balance of Investor's Account shall reflect the Shares beneficially held by Investor. A deposit of Shares is made into Investor's Account when the Escrow Agent sends payment funds to the Issuer or a seller of Shares, as the case may be, and the Record Owner receives a record from the Transfer Agent of the number of Shares that Investor beneficially holds. A withdrawal occurs when the Record Owner receives notice from the Transfer Agent that the Shares have been beneficially sold or transferred.

### 2.3. Reports

Reports relating to deposits into and withdrawals from the Account and the Account Balance will be available to Investor daily by means of a section on the Portal to which Investor may log in.

## 3. Services of the Record Owner

### 3.1. General

Investor and the Record Owner understand and agree that the Record Owner will be the legal but not the beneficial owner of the Shares.

### 3.2. Ownership of Securities

The Record Owner will be the sole holder of legal title to the Shares while Investor will hold beneficial ownership of the Shares. The Record Owner will be the sole record holder of the Shares on the books and records of the Issuer. The sole dispositive record of Investor's beneficial ownership of the Shares will be in the books and records of the Transfer Agent. Investor shall be entitled to all proceeds of the sale of Shares, net of fees and commissions.

### 3.3. Voting of Securities

Prior to the Withdrawal Date, at every meeting of the equity or interest holders of the Issuer called with respect to any matter, and at every adjournment or postponement thereof, and on every action or approval by written consent or resolution of the equity or interest holders of the Issuer, Investor agrees that the Record Owner shall vote Investor's Shares, in the event Investor's Shares contain voting rights, in a manner reasonably determined to be in the best interest of Investor.

### 3.4. Insurance

The Record Owner and Investor understand and agree that the Record Owner may maintain insurance in support of the Record Owner's obligations under this Agreement, including covering any loss of the Shares. In the event that the Record Owner elects to reduce, cancel or not to renew such insurance, the Record Owner may give Investor prior written notice as follows: in the case of a reduction, the Record Owner may endeavor to provide such notice at least 30 days prior to the effective date of the reduction; and in the event of a cancellation or expiration of the insurance without renewal, the Record Owner may provide such notice at least 30 days prior to the last day of insurance coverage. Investor acknowledges that any such insurance is held for the Record Owner's benefit and not for the benefit of Investor, and that Investor may not submit any claim under the terms of such insurance.

### 3.5. Notice of Changes

The Record Owner may notify Investor promptly in writing of the following: (i) the Record Owner receives notice of any claim against the Account other than a claim for payment of safe custody or administration permitted by this Agreement; (ii) the Record Owner otherwise fails to comply with any of the provisions of this Agreement; or (iii) any of the Record Owner's representations and warranties in clause 4 shall cease to be true and correct.

## 4. Obligations of the Portal

NetCapital shall notify or cause to be notified each Issuer of Shares of the identity of the Record Owner of the Shares of such Issuer.

## 5. Representations and Warranties

### 5.1 Investor's representations

Investor represents and warrants that:

- Investor is the beneficial owner of the Shares;
- Investor has all necessary authority, powers, consents, licenses and authorizations and has taken all necessary action to enable Investor lawfully to enter into and perform Investor's duties and obligations under this Agreement; and
- This Agreement and the obligations created under it are binding upon Investor and enforceable against Investor in accordance with its terms (subject to applicable principles of equity) and do not and will not violate the terms of the

rules or any order, charge or agreement by which Investor is bound.

## 5.2 The Record Owner's representations and warranties

The Record Owner represents and warrants to Investor that:

- this Agreement has been duly authorized, executed and delivered on the Record Owner's behalf and constitutes the Record Owner's legal, valid and binding obligation; and
- the execution, delivery and performance of this Agreement by the Record Owner does not and will not violate any agreement by which the Record Owner is bound.

## 6. Fees and Expenses

### 6.1 Fees

The Record Owner's fees will be paid in accordance with the fee agreement that has been executed by the Portal and the Record Owner. There are no fees payable by the Investor.

## 7. Scope of Responsibility

### 7.1 Exclusion of liability

The Record Owner may use reasonable care in the performance of its duties under this Agreement and will only be responsible for any loss or damage suffered by Investor as a direct result of any gross negligence, fraud or willful misconduct on the Record Owner's part in the performance of the Record Owner's duties, and in which case the Record Owner's liability will not exceed the aggregate market value of the Shares at the time of such gross negligence, fraud or willful misconduct.

### 7.2 Force majeure

Neither the Record Owner nor any of the Record Owner's directors, employees, agents or affiliates shall incur any liability to Investor if, by reason of any provision of any present or future law or regulation of any governmental or regulatory authority or stock exchange, or by reason of any act of God or war or terrorism, pandemic or other circumstances beyond the Record Owner's control, the Record Owner is prevented or forbidden from, or would be subject to any civil or criminal penalty on account of, or are delayed in, doing or performing any act or thing which by the terms of this Agreement it is provided shall be done or performed and accordingly the Record Owner does not do that thing or does that thing at a later time than would otherwise be required.

### 7.3 Exculpation in respect of offering documents

The Record Owner and its officers, directors, employees, agents and sub-record owners, if any, shall not be responsible or liable in any manner for any recitals, statements, representations or warranties made by any person other than the Record Owner including, but not limited to, statements contained in any material relating to

the offering and sale of Shares.

## 8. Termination

### 8.1 Method

The Record Owner may terminate this Agreement by giving not less than 60 Business Days' prior written notice to Investor and the Portal, provided that the Record Owner may terminate this Agreement immediately on written notice in the event that any of the statements set out in clause 4.1(a)-(c) become untrue. Clauses 6, 7.2 and 9 shall survive termination of this Agreement.

Investor may terminate this Agreement by giving not less than 60 Business Days' prior written notice to the Record Owner and the Portal in the event that the Record Owner is found, in a final determination not subject to appeal, to have committed an act of gross negligence or willful misconduct in respect of its duties as Record Owner hereunder.

### 8.2 Existing rights

Termination shall not affect rights and obligations then outstanding under this Agreement, which shall continue to be governed by this Agreement until all obligations have been fully performed.

### 8.3 Website

Effective upon the Termination Date, Investor's use of the Website will automatically be terminated and Investor will be permitted no further access to the Website until Investor has purchased other Shares.

## 9. Notices and Recordkeeping

### 9.1 Form

A notice or other communication given to Investor under or in connection with this Agreement may be given using the contact information Investor provided to the Portal.

### 9.2 Method of transmission

Any notice or other communication required to be in writing may be delivered by email, receipt confirmed, to the Portal or the Record Owner at the following email addresses:

If to the Record Owner:

MG Teixeira Inc
mannyteixeria@gmail.com

If to the Portal:

Netcapital Funding Portal Inc

## 10. General

### 10.1 No advice

The Record Owner’s duties and obligations under this Agreement do not include providing Investor with investment advice. In asking the Record Owner to open and maintain the Account, Investor does so in reliance upon Investor’s own judgment and the Record Owner shall not owe to Investor any duty to exercise any judgment on Investor’s behalf as to the merits or suitability of any deposits into, or withdrawals from, an Account.

### 10.2 Assignment

This Agreement is for the benefit of and binding upon the parties and their respective heirs, successors and assigns. Investor may not assign, transfer or encumber, or purport to assign, transfer or encumber, Investor’s right, title or interest in relation to any Account or any right or obligation under this Agreement or any part of any of the foregoing unless the Record Owner otherwise agrees in writing.

### 10.3 Amendments

Any amendment to this Agreement must be agreed in writing and be signed by all parties hereto. Unless otherwise agreed, an amendment will not affect any legal rights or obligations that may already have arisen.

### 10.4 Partial invalidity

If any of the clauses (or part of a clause) of this Agreement becomes invalid or unenforceable in any way, the validity of the remaining clauses (or part of a clause) will not in any way be affected or impaired.

### 10.5 Entire agreement

This document represents the entire agreement of the parties, and supersedes any previous agreements and understandings among the parties relating to the subject matter of this Agreement.

### 10.6 Joint and several liability

Investor’s responsibilities under this Agreement are joint and several if applicable.

### 10.7 Counterparts

This Agreement may be executed in any number of counterparts each of which when

executed and delivered is an original, but all the counterparts together constitute the same agreement.

### 10.8 Governing Law and Jurisdiction

This Agreement is governed by and construed in accordance with the laws of the State of Delaware without regard to its conflicts of laws principles. The parties agree that the United States District Court for the Delaware shall have sole and exclusive jurisdiction to determine any issues arising under this Agreement, and all Parties to this Agreement agree to submit to personal jurisdiction in Wilmington, Delaware, for the purpose of resolving any issue arising under or related to this Agreement.

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** CliqRex Inc.

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** DE

**Date of Organization:** 01-20-2022

**Physical Address:** 1569 Hollywood Ave, Cincinnati, OH, 45224

**Issuer Website:** https://cliqrex.com

**Is there a Co-Issuer?:** No

**Intermediary Name:** NetCapital Funding Portal Inc.

**Intermediary CIK:** 0001669191

**Intermediary File Number:** 007-00035

**Intermediary CRD Number:** 283596

### Offering Information

**Compensation to Intermediary:** Up to 4.9% of amount raised for a successful offering and a listing fee of up to $10,000

**Financial Interest in Issuer:** None.

**Type of Security Offered:** Common Stock

**Number of Securities Offered:** 20000

**Price per Security:** $0.50

**Method for Determining Price:** The price of the Securities was determined solely by the management and bears no relation to traditional measures of valuation such as book value or price-to-earnings ratios. We expect that any future valuation will take the same approach.

**Target Offering Amount:** $10,000.00

**Oversubscription Accepted:** Yes

**Oversubscription Allocation Type:** First-come, first-served basis

**Maximum Offering Amount:** $1,050,000.00

**Deadline to Reach Target Amount:** 06-30-2023

### Annual Report Disclosure Requirements

**Current Number of Employees:** 8

**Total Assets (Most Recent Fiscal Year):** $3,449.00

**Total Assets (Prior Fiscal Year):** $0.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $3,449.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $0.00

**Accounts Receivable (Most Recent Fiscal Year):** $0.00

**Accounts Receivable (Prior Fiscal Year):** $0.00

**Short-Term Debt (Most Recent Fiscal Year):** $0.00

**Short-Term Debt (Prior Fiscal Year):** $0.00

**Long-Term Debt (Most Recent Fiscal Year):** $51,839.00

**Long-Term Debt (Prior Fiscal Year):** $0.00

**Revenues/Sales (Most Recent Fiscal Year):** $0.00

**Revenues/Sales (Prior Fiscal Year):** $0.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $0.00

**Cost of Goods Sold (Prior Fiscal Year):** $0.00

**Taxes Paid (Most Recent Fiscal Year):** $0.00

**Taxes Paid (Prior Fiscal Year):** $0.00

**Net Income (Most Recent Fiscal Year):** $-186,802.00

**Net Income (Prior Fiscal Year):** $0.00

**Jurisdictions Offered:**

ALABAMA, ALASKA, ARIZONA, ARKANSAS, CALIFORNIA, COLORADO, CONNECTICUT, DELAWARE, DISTRICT OF COLUMBIA, FLORIDA, GEORGIA, HAWAII, IDAHO, ILLINOIS, INDIANA, IOWA, KANSAS, KENTUCKY, LOUISIANA, MAINE, MARYLAND, MASSACHUSETTS, MICHIGAN, MINNESOTA, MISSISSIPPI, MISSOURI, MONTANA, NEBRASKA, NEVADA, NEW HAMPSHIRE, NEW JERSEY, NEW MEXICO, NEW YORK, NORTH CAROLINA, NORTH DAKOTA, OHIO, OKLAHOMA, OREGON, PENNSYLVANIA, RHODE ISLAND, SOUTH CAROLINA, SOUTH DAKOTA, TENNESSEE, TEXAS, UTAH, VERMONT, VIRGINIA, WASHINGTON, WEST VIRGINIA, WISCONSIN, WYOMING, B5, GU, 1V, PR, VI

### Signatures

**Issuer:** CliqRex Inc.

**Signature:** James  O'Loughlin

**Title:** Principal Executive Officer

---

**Signature:** James  O'Loughlin

**Title:** Principal Executive Officer

**Date:** 03-31-2023

---

**Signature:** Timur Akilov

**Title:** Principal Financial Officer

**Date:** 03-31-2023

---

**Signature:** Timur Akilov

**Title:** Principal Accounting Officer

**Date:** 03-31-2023

---

**Signature:** James  O'Loughlin

**Title:** Board Member

**Date:** 03-31-2023

---

**Signature:** Timur Akilov

**Title:** Board Member

**Date:** 03-31-2023